ذدà،±ل>‏ے =‏ےےے‏ےےے:;<ےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےnً‌N؟ï<‚'يغOظZک<#ذُ®ے‰PNG  IHDR€{¨iT pHYs.#.#x¥?v MiCCPPhotoshop ICC profilexع‌SwX“÷>ك÷eVBطً±—lپ"#¬بY¢’a„@إ…ˆ VœHUؤ‚ص H‌ˆâ (¸gAٹˆZ‹U\8îـ§µ}zïييû×û¼çœçüخyد€&‘و¢j9R…<:طڈOHؤة½€Hà وثآgإًyx~t°?ü¯opص.$الےƒ؛P&W ‘à"ç گRب.Tبب°S³d ”ly|B"ھ ىôI>ط©“ـط¢©چ™(G$@»`UپR,ہآ ¬@".ہ®€Y¶2G€½vژXگ@`€™B,ج 8Cح L 0ز؟à©_p…¸Hہث•ح—Kز3¸•ذwًٍàâ!âآl±Ba)f ن"œ—›#HçLخ ùرء‏8?گçونلوfçlïôإ¢‏kًo">!ٌك‏¼ŒNدïع_ههضpا°u؟k©[عVhكù]3غ  Z ذzù‹y8ü@‍،Pب< ي%b،½0م‹>ے3لoà‹~ِü@‏غzًqڑ@™­ہ£ƒ‎qanv®RژçثB1n÷ç#‏ا…‎ژ)رâ4±\,ٹٌX‰¸P"Mاy¹R‘D!ة•âé2ٌ–‎ “w ¬†OہN¶µثlہ~î‹Xزv@~َ-Œ ‘g42y÷“؟ùڈ@+ح—¤م¼è\¨”LئD پ*°A ء¬ہœء¼ہaD@ $ہ<Bن€ ،–ATہ:طµ° ڑل´ء18 çà\پëp`‍آ¼† Aبa!:ˆbژط"خ™ژ"aH4’€¤ éˆQ"إبr¤©Bj‘]H#ٍ-r9چ\@ْگغب 2ٹüٹ¼G1”پ²Qشu@¹¨ٹئ sرt4]€–¢kر´=€¶¢§رKèut}ٹژc€ر1fŒظa\Œ‡E`‰X&اcهX5Vڈ5cX7vہ‍aï$‹€ى^„آl‚گگGXLXC¨%ى#´؛W ƒ„1آ'"“¨O´%zùؤxb:±گXF¬&î!!‍%^'_“H$ة’نN !%گ2I IkHغH-¤S¤>زiœL&ëگmةقن²€¬ —‘·گگO’ûةأن·:إˆâL ¢$R¤”J5e?ه¥ں2B™ ھQح©‍شھˆ:ںZIm vP/S‡©4uڑ%ح›Cث¤-£صذڑigi÷h/ét؛ فƒE—ذ—زkèéçéƒôw † ƒاHb(k{§·/™L¦س—™بT0×2™gککoUX*ِ*|‘ت•:•V•~•çھTUsU?صyھ T«U«^V}¦FU³Pم© ش«ص©U»©6®خRwRڈPدQ_£¾_‎‚ْc ²†…F †H£Tc·ئچ!ئ2eٌXBضrVë,kکMb[²ùىLvûv/{LSCsھf¬f‘f‌وqحئ±àً9ظœJخ!خ خ{--?-±ضj­f­~­7عzع¾عbيrييëعïup‌@‌,‌ُ:m:÷u ؛6؛Q؛…؛غuدê>سcëyé ُتُéفرGُmô£ُêïضïر7046گl18cًجگcèkکi¸رً„ل¨ثh؛‘ؤh£رI£'¸&î‡gم5x>f¬ob¬4قeـkVyVُV׬Iض\ë,ëmضWlPW› ›:›ث¶¨­›­ؤv›mكâڈ)ز)ُSnع1ىüى ىڑىي9ِaِ%ِmِدجض;t;|rtuجvlp¼ë¤ل4أ©ؤ©أéWgg،s‌َ5¦Kگث—v—Sm§ٹ§nںzث•هî؛زµسُ£›»›ـ­ظmشفج=إ}«ûM.›ة]أ=ïAôً÷Xâqجم‌§›§آَگç/^v^Y^û½O³œ&‍ض0mبغؤ[à½ث{`:>=eْخé>ئ>ںzں‡¾¦¾"ك=¾#~ض~™~ü‍û;ْث‎ڈّ؟لyٌٍN`ءه½پپ³k™¥5چ»/ >B Yr“oہٍùc3ـg,ڑرت‌Zْ0ج&Lضژ†دك~o¦ùLéج¶ˆàGlˆ¸i™ù})*2ھ.êQ´Stqt÷,ض¬نYûg½ژٌڈ©Œ¹;غj¶rvg¬jlRlcى›¸€¸ھ¸پx‡ّEٌ—t$ ي‰نؤطؤ=‰مsçlڑ3œنڑT–tc®هـ¢¹وéخث‍wç|‏ü/÷„َû%زں3 cHRMz%€ƒùے€éu0ê`:کo’_إFC¹IDATxعىفïUغJ×ئل{²ٍ‎ر[ءQ*ˆ¨ ¦‚ک bWTTT€SN8 T‌ =ى÷ƒ¶‚P$ظ–هً»ضblK–F3ٍYgnï B+3‹%إ/IC9-µµِںHْ*)é¸ IكC³wش.tًو…h2³ر ÷‹-%}¤ :M$]u<ھ"€€لًƒ؛أ7¥‘¤ں´'3‹TIْ¬b®8Ycûٍں©¤Lز/ے÷â=u ‚Cطلط+&ŒT„>KٹüكQأثSI¹ٹ/°§’²BJ+¶¶يXز—Jû!ٌںqه}R…~†وo¹M €àگx"آِبCIك´^0،|ي¨²/©ـ؟ًُءٹm;ٍv«=D“ê%h¯±û\/@’تُ(ے}af¹¤¹¤ïoqظک _گ+ڑہ>کYlf’‏+éVأU¥ ¸¯cl×بج.جى·¤'لڑبںN%فI: !Ig‏ـX«‡?rےy[ا’.}§’nü}ت×L$=™ظo?®è­´5@p0ƒ^•2<-*ت%5=َ_ہ°ج,V1‰؛‰™ٹoêûîد‘ٹ/«_ذƒ·ë…¤s‎]ي#Sْبت×zّfR{حچٹٹ!#l®b^9َ}F‏ï{؟†±؟vdfsAگkI×~كz¨ى+Vô¹2³{Iw!„üکغœب‏:ْXز×آ-"©;ٌ–I:c},€ƒkَêî ء‍™Y¢"گذƒµi¤وàاجO*÷گ©™]ّ؟ث×f’nB33»ضK`مR/صA2،ڈG؟vںCںجl¢— بXEنقC #½’نzYٹوJزù±AXfw‌<ٍِ1د*J=hyإ‹÷dشٌـ”ً€!yّمI„?†lس±¤g½:rU<‏/„0 !LU ‚ّ²0·µ×‍xّ#رKذlB¸«¾Wa®bùI؛0³qaBّ¤",’û~¯ü}üµ©ٹ9詤O‏‍^+é·Iژگ!„ëذm±b'؟گTv\në_‡­`(•ًGDk ز‍‘™=ھ¨بûأ7’>ù¼{^¾ضƒ ے³|mھ"ّqBب½ٹب£?—Iڑ6½oلز·•¤كNù¤¢زGُ}2Kدن‏؛ـ«ƒ”Ayںx0³'_6وhظ np<$@ّc¸ِ«(ˆ0ِ‡j~T^«؟Wˆˆُzچr©¨ض‘wآ™^*xN¶¾Hق_¤b.ُ,„ذ¹ïBjf§ق‹%¯؟زKPdZخgûœnى?_|_™¤ï•ëگ†ٍJn –ô "èرt\ ?®ٍ|‍جىشڈ7ٍc¹¨\ë©؟gùْG3›zکdS؟†عكG3»nynBXlpٌc½¬÷³ٍ¾×9ڈsëإ-û“ٹ”دIَu'َحlز²ï¬قّ‏ع¦›Fـ±ے®´صه²Sغ×XزWoڈh…×gق6ك×yں-ُ‰/-ڈا}¢ٌ:¬p c؟NةٹغlشN~Cj»©دêAœت1~رK8¥¼‍‹¶›€Nم ·د%ف«کwNùDآCî/UQù#_e[o«tة‏c½.îkث¶,*¯»–@B× ï•›ظچٹًابجFmظ„J8¥¹T‏ˆ‎e©ٹ Kوïےة_ں¨¨ـ،B ه¹n¼؟`‍گhpسش`kt€‘عKة´î»مxf¾îOYيمVيa‚خ¹خyy@cشًش"„pZ{يµw†،œ®آٌ¶~ذfهٹو*'ظo2]}¢¯؟®Cا مھGںùë‎ش/کَ¸ى¯xŒ ¬!„@#`pحûœêُô]rں‌©ک'جڈà\½„نا}7ذ‏Rصآ•B#‎=g‌û8ے©"8“µ¼اƒٹyز\ز§¶v®جةwخ›ظo?–¥َة يUjج5x^، پHزة&پ ےçتC½+پ|8ہ‏کµ<WN‏·ْMنG’®جىظ/ت[¸Qفzçٹ7ـصXزَہkJ]ّ€™ °»‘·سُغن+مxہcًعhƒmg!„é‘„?"‎fXl°؟X-ل3›xذâQإSwهûâG~SŒ`>÷ـ.“tyDçYںOدûV§ًùôr3WQ™"7³بWزè³JإHإ\‎“‡/نû‍©XضهnˆFً ™ےyصpn#ںïm*>iI`بC g~ى‘ٹyِhƒC^ش‏~¬´دت>ظ |Pû$y®%ëص$j_–مàUJàt™ûحèشخT$‌–µسCںخt¤m$oڈ›عد\ث+wLپDاـ€#ُـî‏*HVڈHj/6طeu§!„´²bاhأأ©¨rBبCSI'7Iµ Hâء• 3{V”™َّ¹؟ِےTجKزي²ھ¬)——‰µظ¼ïد†‏؛ِ‏>ر€lê@ I÷*ضية+;ِ‹u¾d ڈجlزw‎œ† |-é؛a ]«!Uنغ„÷Bفء†;µ—ئ™K؛ِھM7€²3=T:ëPزژ}~k9§Tف‰؛¼gIEٹى¦c‌©ب÷qصرڈ&fِsIت:‍[ضGQ¦—ةصMِىJـs»ù1œœدے^4<ُ£ç‏&z™o‌VآC¬طQuef_$‌ ´ !ججىت¯}سq—÷±yeY›©ٹ9ôXEژ“®مٍv™ھک_y ه؛g?»­=–¬»؟`fضٍـMد«v°§u÷ي¥bFKvںK؛\ـً ü[uزآIا>عژgB8]±-®5Pؤأ-د-ƒ*÷ء7_q_‘_£¤ه%§!„إژnHmm´r;×عè÷’‏s؛j©#ككcG;ه’>u üژqضط'‎Fœêuہ%ٍںںد€Uُّ.*°3]S(ô] ـ׬دvلH:¢™‎Vsبهےض Vشو¤g!„©د-?«گf™T4Yrl×*و•ےڑGِŒB¤b^÷‹ےژj»بU„-¾·ح…{ذهظے¼ !\®ذfصص)Nْ,»س‘MّشVش îمژح\+Nق{G‍ْX‍´¼,1³xص;]ص(.W ”يcfgjKœk³’@ûٍ°¤ےœ¬s½C™™‌z;5µ}¤"h4à¦v¹,tسَ³ ہzزc8H¯ض7<5ëYUمAإh¦—ص®´½ً‡T„5‍ج¬\jf¬×K ¤*وzثcH<0¯q\3_j¦“؟ےچںَ…™‎èڑأُہL\k؟>ثظ|WsنJ+خE8آAv³nZئ/b¶¤3أہچشd™ُYتئƒw-Oڈ‎=ڈ†§±F/9يٌِمYاK&¶UھV\°T~$اyصٍّ÷¦ح¬unسج.ô2ك:ُ¢±ڑ——Z$éءج"/|0¯<—ّqإ•×Vے®Z¨کںJْ¤—Fkث‌^2·-myE’كµ}'‏¸:عزًش¼¥دMü,ulگ,„p×sغïد%Gr‏مژç6Ycي{د÷ثجّ¨ذإ«W\ش&‏G /‎S‎أ—)yزë0آ÷†}اzYٌಜ[ُام=œîصہû›ûïٌڑغ•U@b3û-é©زو I'^m$—‏Tٌ¸ôç'>‡فdل؟#Iڈe°§£ H\[¶ç\ +TS$غd“¥?d0اj7 qnmm›Q3چ:‍û1àû¤×i´î¾6©قàف(«WŒ+ڈ% ¯»”‏F‍ُz5k™;؟ھ0FژFشٌـ“mHأ—ذ9¨6¸Lضَ:5ùE×ذإC±ے9jyظ"„p] Dµçs½,…RصV‎Cعoء€رہû+د}¼نu‘ٹ&¾û6s½„5âUق¨Vن¼هeMK½Lجىء—ً¹iظîKهك¯خ…بٌHh‚قm”ü>Yاsں¹ 6ھ‏af£عَ©¤3_6هAحءچûB^غO¤—ءحoأjBHC‹آuل,„p¦bY‌L-=Z”ي9iZخ¦©ڑکظ…/3[زھa xS¢–اس8è«‏Eô‘ےN‎çشأj‏â|&é®لٌ±ٹ9خ\حصAٍ=‍s:نخ<ط<ذٌ‡™چüçعئ‏wTظvBّ¤bi–dإ·œWعoزٍڑ¶ذح­™%!„©^B iCًçصك'´¤ِwù.iBب=0nظ‏¦^‎أ•ث“ج[‍O÷xخYںچ*!‰طزآ¼ٍ|نيôUK–ƒ1³TزBEُ”¦%rZù5™«œ«!€Bک™ظ•ڑ—–¹Uى™ڑظ؟¾؟ْë"3‹تkGنm¸، àحJjG’B¸«2³Q¹چ?·مB"ٍ&T.6ڑچق_×ح ¥¹ ¥،êƒT›ُھ£–]L[ûï¬-شBHحl§‎}ةَ‘–دد| ™Y"éQحٹUچ%چحl&é²¥bJSûe‏¾كش0ںBXx¸dـ°‹sy¸أ}ixحںs"r<2ڑ`©…†{4I:‍û—¬أ—#©کƒّ¢bb3ixiھâغّ™¤Uجچ¤«LB¢³‎c½|ثے?ê‍ *¯أےقbû{[ؤق×i‹Tث+6 ؟¸يقQéكZ¶½ë¸._‎÷|ةû/´›yطR®†هRj2½‰,ھ‎²:.حl"éaہم›¨‚œ­X d.ébI^َْQيٌqي:wِڈڈ»î„è-ë¸'ـL—~Xچض,إسهَ’9€Nْک¨ک´MVـ¬‏؛+كW¦b‚ٌgaNë®شِc“ك#­¾Diشز‏كڈmخ®ز_ü¼â‍mQîO*&âJڑ3‡¹u‰^‚م†ç3I7+\؟ںKقç§v™®¬تVY)أجnU„/†Iz2³›ژم‡Cزو!dfv#é¶ه:ح›ئ\گم‘-ikn‍ف7‍êحoS]ƒٹë8(^ِ‏¶ا¦iلٍ@خل©دv!„س¶×ه*“ف^aلJEّc(±ٹةإ 3ث%ح$ف‡²\ëymآْرXEàf<ً®«يں©¨Jpwب•A|¹گo÷أزب®*لکAûممt]IكûOإ÷آl÷ù¨ل©³¶~è} ´Xٍ ؟oيآفPA63»ضvآUWfِO¹شLث‎nQ¹Uژ‎فô؛;3+ƒi¯ْ،–Wi‘شùد†'ْ…ے¤ژ'~؛عz¾açں¨9´“mû†4 ®ے¨ْ¦هe‚6¹y–m•ر[&زn؟¹½ £#h¯¨ëI¯´p«يL¸×ڈمBEa&éو½د_ّ<ط•vَِطكëـجîu`Aںô؟علکٹ+‎q®"²8¢ûعïَs‹ا—¨g4ف.Ci¹ؤTC¨¢<¯إُر\فKْŒû]کک™؛B zYFçsأ±&’ن!آ©¤çع5‎ى¯[zû°¤³ômجّ ü‡ؤ!ڑ·<>`ك>ê?انéْ°HV+8ïù‏à‌2³ I؟µ‎ًGفDزoےü{l÷‘™=«ک‹wüِ‘ٹ¹¶ك^ydكmQV²xز‏وqا*–جxhق/!پْ5‌y5‰ب¯yز°m9œ®ً>»؛^é²0Jل:N;ْûطا‎Nï·fضُ‍e(i¹ژOf–x`oعr‌—^‡®بب;DWŒµ­hK‡إµ=kكً;‍‏÷XاoَmُKے êْ³{؛((™Yن‚·ZR!dث®جىyةœذ[k÷[µO|ïR$éرCر‍عمZEEپرپ\¢‰¤gFax©¤ث%لé%Lًk…}‍ةطڈ}ى?î«owîRے=ê¸W”!گ¹‏پ¬نƒ؛«Lz4êD»O/¾َژç6Yمê¼ç{¢û%n“¶®ؤضb•u‎ہûP™|‌ب!%*&اo¼فo÷‹;´‰·´ث>èU?ٌثû‘¤[3{ـW0وبd+¾.•tê_œ_€ٹWظ·‡ط’‌çعE*¼؛حؤجUTZع÷ط؟j™“N+اwŒ‹'3‹C3I³ك3/ےٌAزڈ%—¬ر¸ع})•cے­ْZ/÷زv‘“%%e؛ق؟ي?<²c 5ّڑa‹ژ—<ِI·zغv]«z3گ^…?’;´Hإ\ةنچ¶{r ي^JTT¾Hvش؟u8U?عŒµم`ج1ٍyâ&ے©ü{&, mTç¨}~µٌ5¾„ز®ïٌ’¾‎d*ھغ‌¬طFei¶®غ¼يئق—T=¼µJ jyض~—عYE,ںـفb[$ق£#¹|‰¤كïe‰¢ ¤-m'I³آشأc‎=·¹hظgقذbںûكُ},U`I;ِْH‡j’¤¸e)ک´vف$5†pyِآ+پL›¶kê·‎اYه?&ûتشs‎%ً&يr¹„چژ³c‚£âقا´JA¬-U½8آًG)ٍ> صëY£‹¶×•ص%¼‎ڑئBVû{ن؟سعû]¨کيلt¬ً¥ûôˆ.كyأcy¥؟/»F“²RK¥zHسv©/ù#3‹?ْƒ7~—}­z،ç’¾ëpض4غ·إ ¯5´oش2€¯حىKاُˆ‎ùàï‌IْWزgnظuخ%‌sƒ{‎³¤N|àdقF?%‎مm´J_د%‌• ¼o>y:ق`‹†اF[:ـHإ—¼Oژ¼ح ‏بüü«b¢9¯]‡ےhµ9صU$*¾ل?°-b ‏ب½-~y»d•çbےùاغ#èءکSوك‏x0³KےüOIK^غp‎َژ%dت¾i؟ث¨نZaNف+œجt9„بج&k]X4œ×ƒ™‌TئCضِ¹ل×ًٌc¥،خü&؟é +ُUآxüسS3[ ü}¦صتîŒz ®سe7پ#i÷iQ fé  üگZ§­2لڈ”ôRUsI?$-؛وf|bo$é‹ٹ عx cNجى"„pwŒ ^Yn'ع`7¹_‡û%َ>‹عûNT|أ“k11³!„ù@mٌ¨حأ3•وk¼wى‎ٍ|€¾™hà`ج¸¯<™ظ§آـ؟ط^mمں•ë0Rَ¼èbةُK¼ïؤ{<دûھ”‏=¢ëw®×+§üô{ùç†×‏jx,Vْ¹ِ؟›>'î‎÷£¤نCù¨¨œْ n“‰¬f—ê^ f-!„<„p¢îه{ضµگtٍ–B !„éذmïcن„ً¨hْو}“Lإـإے…خB³e_جُy،yل2„ًIإ…سپژûꈗفط4ً0W1ç3]gقا¯ا‌ٹê)7›ِ›پعےJ›}A!é“·إ|‌ CYلخûوTح“شëکّ²>]ï¹kêغ.as×´Eâ}¼¬rَ}Ihٍ³c›Xإ’/ٌ‍ئpîchiں3³‘™=i‎ ف>%-م;j¹59ï¸G,B™WںIز‡†›ص™ٹ بL«OڑدU?¦„?ZoB©·ëbà‎^°كLز4„ً&*4´Qù<غpW ïç,ûêâ^s£"pp·ة\ƒ‡ANTI6iù²§:لظC®bnىl“¹1ں[½Vبة7è7¶إxأ}\5Oèث] 1/÷pؤء¤mûu¾kêk^…¥m<ج7¼omس4„p½bk¤ي-‰µصk·âطةش‍ٹ:ِqم×‏O(وcثخ*&»§^*&n¸ّ¹¤´£Kھ"کذ¤ëوq©وؤK>@مîُxتHeئ*ت»Dµvû_ظ¾+îw!iQ)¯ôU/i0u\ں…ٹN‹èّ35‡X†¸îه€™ڑظM¥چV¹A”يô}أٹ}ْx2maiùآ‌™-´ù2(كô²ؤہء«Ox®)Wٌ…كtہëP.حٌـsçfض+ن!‰غCi oڈ\إ¼ـO½T®XW¤×K_ ¸خ'*ھ¬<ْcهµ;oظ&فC€™ٹPQîثث$z™›چ*ا}³fµ™ôH¯غç5^;Wsکë\ز,„°0³ٍ±;ےû،zےŒ“·ح<ُA‍س2¯‏!nْہ;ش%^*ƒ€UŒTضµ!œآ Xدے9قgظں[yًًS“ىùغ'QےًAé¤دـب¦×¦kَ¶ثç‍“‍çy¶î'k´إ…ْ‡1.½ھ‎؛ïy­~aک\[4كD‎C R±,M¶اûب^ïƒ ا|B¸®ŒپO¾ب³ڑ—jىWô›e2_ hèv©AŒڈً3ّOھ´{c؟Zr/¯^k©(@گش?¯>ًكق| c‏AEبa|¤×0Zل؛VïهYث~F‏{لم7oے@€ل¥عAّ£نلƒtƒ]Œژ¤]ûزآُژï¦çv±ûm±ص LCك¼Tû¤ِ28¼Wُv‹$]„ٍJ‰¤£دgRمھغ’x0iHٌ‘_أêُùâ؟ے­¾ v}و]يB¸ !¤¾ح_ו0¬\إR#ùژكw“* ة،7ھO,ڈِذ6+ !,ش?ˆ3Z£-"ُ«„’ي(S7ي¹]¤م­ü°-çµPL[؟¹÷¾2’ôطpڈع–رہûثقة5½®^·_j7ہ€أ؛/؟y؟K>è‎¾;¬ذWكٹ o›‌]ے‍غ}]مµ=كمrخغ؟ï5xدثہülx,زًٍO®—J’¢عّN·xجں‡ع‘™Mشة§Cûïْ}z,éتجےىX,i—XحA›`8ûھ°P؛ك`غّPص+Œ{n~³مأ]ôـn´ئk؟ُط؛ث¥_ى›غXVنhî'-ڈ/ إجC¹W•ˆ{ô¯M$چùXExه-‰ë×µ¶ôس­ے‏¾d?ma¸Œ0œï{~ےإغئـ®c•ض•ي¸ْ‡üüiںmk“ءm¯ُ¼V÷û¼€>ة{n>z§÷“¶¾›ظ¸c»M‌·\‹mژ‰d ‎Lقز5¬چي¬ٍïê}mdfمآL-لں%ث?‎" g¶د7!¤ê?ة~ب¾ِـn¾§مM{n­ًڑ>ص?ٍ=¶إ×مث{¼™xک([زê}mوغفضْS½ ³-v$شا‍T mص–ص^_V¹i¹^“ژ÷b ` imbooاٌ–uأه_ِU‘هك‍غچVxMں¶X„ٍ¸œ?¶ط.oص¢­ّ2)ُ{خحٹc&فâک}د׫î—ےN–\دRـR¤ـOغٍ?Y!% cq ا‘¾±vُـ.÷ٹ(o¦/ّ2QڈMyكŒ=شًu]»‰÷ٌجے¾َعd…~ٍk‹ا°ڈ™قF5£ٍ^ًeچ1PVw¹¬îgةٍOsIْبç00ˆںrے{cيعwùڈإڈ9سكK8 qج£#l‹?B™™هêbIt8!«]¶ظـج25Oü“t­bٍ\ésكVىW[:ىx ¾2•ôxؤ—/!,jcw•د‰±™إ~يç’’BjfغـK13këx!„س=دSاسiل²e»ë¶پB{jغëژء{Zétè/م8¶bشs»½r¼ أُv‎eƒم9iدk:ز; €¸ïj‍ïچ½*جwI?B¹/ “¬ذ'يSôûg q47³S!گè¯غ\’جl\ylص><–t'iھ—ه|ئ-¯]”cœ أگàعمr#uظkع¤çvéىf£غ,قب¹ےçك^î$‌«9ٌ­V¼`¼ئ~çk¾~Uٌ€÷ص…‡@6¸ىثwے‎gù—B¾â¶_T,é“Kڑyˆ$jyيںjCّ(6–رأ3³ر›§o¬-bg„؛¾•Y’÷:<ذ¶¤ذ¸ِ÷:Ub~léگمپد?•t*ivD—mQY‰£¼Fك×ط¾~ïûعٍ؛yuإ ہو2ڑ`+’¾®ٌMûc÷ـî'فèّ…îش\ح¥\¦O?YX_يد!„©ٹ%Qژءچô'ؤV¶ا|چي#3‹*ڈ^“×غƒ€CُـnٌغbD_x÷¦*&‎»ْFز²ي_غ…2­JXY-¼0کآLإ’8‡¬Z•م›ےN½½ë²ژ‎$ق–‰ڑC5سzذي#cطXFlإڑàڈےôـî›™R;ئ=·KقمE÷ةےQل.„گ™ظ©¤ç†qr·dW؟Zے،؟—‘B¢-±B—f6ض*چ ôY0ُkiùٍ/«|vŒ» !ج‎}F’âآŒ°¹i‚ƒ’¾ءsJznë0'ت±ڑ\ز­™}UQٌ!5³©¤‡>}£¬جQVژ!ججىVاWaه^زي^«³JUژI¥]gµë·Tiٍ¹ِ÷,„pي×ٍJز…گ?)-l]Düسïض¢2حىآç¬Oô÷2+yث>2ے‎UزطC¥ظژ9QXy0³±/Sزبأدz]1م³™=ڑظSS$„°8 ë“©‏ًc.اىMهٌDEه’±ںG¶و{ـy[>é% —•û!‡/¦ ق­µ؟oحى!„گ…N%]Vھm¤-ûبü÷ب_U–ƒة´‌H¤"شٌ(éة^û¯<TT$‰jغ^¨IŒôwإ’C’J:i("QVّکصBه²5‘‡Aھ×و•Jبه§؟اآƒ%Oµِ*_G€CBکëïتO(„pW ¤-ûب0ت¾–4<¯ت@H%}ïHX zچ‎ط¾Tخµ<كجت10çc ؟آ¢2/ ¨ِ0iyîآج~ù\‎‌ٹہAند-:ِ™کYRخ·†ffِMأ+6±è_جô÷²*µoل®د†>÷\5ز†‎Œ;îu™دُا•ë\خء?.9ق¼ْہا%™xƒچW8§ؤ&fv«"s7tPآ.ç+Sظ!جl®"±Xم­IO-د‌.$C‌ëXز­ڑ.MbI>¸oڑضZرmث€^ّ¹W;ٌ…¤oا¸ذ ¥w*ûھقˆ´آ5ùùf’.× ^t]م3UزRfv½نطbے)ڈ'كضض°ة¼!ب’* R17‍‡وfv£bق7]ل ûكô²LŒ$M%=kُyغmةTجغvµG¦صçس—I7ط¶؛ôث´ْ„دû/;ئ²jثـأo‘ٹ¹ى¶kگ5…U>´يفCدZ-üQùء={ˆdcfù1=ُ8¦±¤'ك‏àù¹>¨Hَôي¬Wfِècا8’ôغ¯s<ہ¾‍}_}ڈ7–ô8à9'~l±™ُ9¶r üِ ›؛T2hَà=îT|Yےr…}ژ«x`d؛آvsُ+œ°PQ¥dھ¢ء¥?V‍Wودں¬ًeûlكؤ‹ ”mxس°zإ×ژmےç‌ںثt…ً‡ع®دا†7(w– p®±ٹàإiں%:¶pLf…¦‡:Znے±^ض&ZGçZI¾$حأ@ç;ط¾*ç{ںë¼,+وث mڑl‹TS¦»X oV¦ل*àH…r3›ھ}iگHإüن‰¤³W+ˆ«ثہّûج—T‘ٹ21Œ%}ixحOsض©ٹھYأk*} 9&FZ3ذâإتehf-KبŒ;®gZ¹®'‏ûAفyپyغê'kiµًAyپتشُْHEنسKaj¸²Ff–­¹ ïقPصوٌî|~ƒç”‰ô'œ1W{° –ôB8[c·ُe`Bکْ=¸é><+أbH÷ًù0xL|•t½وçS9ك‌ھ،عٹD¢¯knfêفdê¨خR¯r«î‰ُ™¤ûz5ژ\H:o9ّHإdْiڈFµ<>W‘ھKâe´dںWf6[a­£]wذeيںھHQ-Z¶ڈU¤‹& |‘÷‘h€s­†¶ژ{£"½”¯q®ْ‚™]oôiêث¹÷»z)?©¥ŒWhçIںّH`-Mً®-´|îڈ~ƒ÷hھbn9ny~ـ0_ڑwى¯mœ‌ھX5،‏>?÷yٍ^làvàف&f6ZهK‎>ك].س’«½عت—ژفن û\vN‌U]>Vv6Vûdzyہچ'êopي)£¶µhF«6ضsy)™–€;Oْ,«قp®صض;عU©ر´™-[؛¦\‹ةج¾kطê¯n¾™^/7َ¥é&âپ،اپخُ‡ٹ`Eس¹nô©ïïFز]ث`ڑK؛ô4ضUG»اf6a)ضر كH*¾,>âزBْS-âLيََR1_:¯xّ¥ِùقؤجâْـjاûd»8OEŒô²*†¶<nµd¥‰†ًاiاœôxةک.÷©{]’¦ُbuj'زوl•à†؟YW¨â|أئ¾ !œ-›ذ÷c=U؟س¾\u<7_ˆèq‏CبU$ث‏/„pBک†®+?§-ًBيI´ظڑç:كrں+زُ²%Œ|=§eي‏چڈ#ض’ذïZJ؟ùمtTù\ى²e^=\ _êï2êxںٍَْـص‌¥ک…VZف¤¬زU•à¾Gƒج;.\ںNگ­zB5wK:Qt م²³‎{,تA8×ٍW™wو¼دہي¨›,ةسضO£ n<‹uBG•vں©£نرگ7Bقپک&x×l›¼±¶بznرچق6ںںىZ©à¢2G9ïطص¨2v~›ظmي}زتûD’‍¼طD/f›ظ­Wْxشf%†61³§2Sàçù¬îًاXزoI_‎،®ًUBH}ے¯»Y§ˆآOîŒZ‍ں/[n¥إدپ÷¦gGد—|(تM؟«#د6ـ÷‎ژwع7”RéىM|“ًإ 7ھ]¶فœڈہ‘‹ن8F\ٹw-غ`غdںîغO=~ا^غ2‡قط ںk=ي3eک£kî=ِ‏Wِµ 3{®V¨„@ت×<ّr-رccbfO*آ:ـگزHEوQ/!چLحلڈ[!–¨ز6]ں_هu¸j9ے\إ¼üُ:üqة›‏طàF¼ً?و\”ôگےأہثؤ´uè´g§:ذçf–8h6 jŒ¶pچBبح,mùûـc—¹WPé‹5طا.ق÷PU!„lƒ¹®}/}’¨ا<ه’ùءEں}ڑظhأ9¾،ئt¼ء½%فàKêïe¼¤fv¢"¬0®÷G3›„ff6S±ؤJ[؟Mkے6³?،ںSپ‡‘ï+1³صو¸=’ّدg?®èˆڑ5ھ´eھعJ~~Oz=O‎¯?قض×3؟±ٹج_}]Eّ#]÷`?.¹ٌ-ْv,©ں!ننCںˆï؛Aےè=®\خ|ƒzW'ے5D_é”}عl©8rfoْeص %\¨ے\×hدا½چ‏›ِ<¯‘6ںےآDEإƒµ…Ca¥vت%‌ùr$·z=?{¥bٹµ1’†"‘¤g3›ْr3هûœڑظµï7Q‘™½إ¦½ !\ض>#لڈ¨aœvچےثتُ¨ت%ف¯[ُ£êƒ:V{‏@¯6خ[ِyç‏kہمفd_]‌|›}m´‡6ثùxˆ|ƒmم=û.$‎ى»،O‚ïœ1:ê±ébKmٌُ@®eك1‌3 :û[l…g_ژeBک‡>Iڑêe.6ِç2¼ë¥ د=ّR'xX،ké™·ًzض‏ک¨9üQ.ا“´ىoو›H/ء¶\E(çSلعج’تRوïµ’ڈoœ2Tv"قءچlبk¹ةہيْگ»ُظ&؛¯y©‏¾›ڈ´كھc® TT¨؟ي¹يWmPل~£‍غeK‍ï;“¨è#ُںدK‌÷ùج—_)+qL|îu¦¢¢ؤج—شْêدد=„PnسنGK?¾ًًآe¹’GaلKد\©yI“c¾÷Lë+–کظEا=©¼كDM‎8„0­}¾‏ًëùu;×ë ء¢¬؛²ٹڈjں”د*{¨C‎ص،\ثd 7{°=ں÷ُئë|مo›OngêW‘flf—ُ ـè[éâç’¶بحl®~ل¨s½,=±ڈ1‌¨_U”¥يIز‌¤o•q©c\کظBزM½ٹ…W›ّGإز<¥‘ے^t¼×DE¨è´ة%]ڑظلˆنˆغ2SüX4ôم‡Z{µُصْ= UQ)¥lû¹¤¹WoyPû’£عv‹آ‰^/=s,r•M>ُ ´ُصYل¤D«?~û>›ئوچ_‡•xûز¾ڑظx×kf±X‏¯فo°يصژûïH‎ھ•d+.ر2ïyh‘ِ»ڈ!’K؛‘ô)„p×0¦#3{ز لڈت‏éû‌V–}i ~´~n‡®×= oك¯ ¶=كأٌقrةPه“ھ‹‍›اfv±أأي8™¯ط¹¤Yكٌى«‌ٍ Y¼حvء7Zْ©‚<–‎!„گzهژ›تëf*B ]"كWزشWC³آ'AگإپµUھ" ٌ!„릥¢¼آة“V[ظ£کY¨”جت‎کظµ–?نm>يsB@p(ع[E ق¹إغژv9aىإc.|ك`غ«]ôc¯ھ0ê¹ù‎ع"’ô°‡k·I¨ë‍®؟؛تR0ù /«¨àq].هBک×ِu؟b؟j پTِ5 !œJْ¤¢JI¶§&تü‎O|Y–YاxژT„?’U>g«ثئّR8¹ïg¢"ّ±j8ى²oص›®Hآًطïp ¸WL3ً~yُ„tƒ]ىdآط'¸bhéا3ُں4ژ¶ف·|n¯oذa±âٍ/e[,ش?ط5ٍJعر¸¾Pےùتث؟ô+©ض« q%é¹eة¯;­&‰´$R~….½*ب‰¤Km؟2بBEe““آ'ےt…ٌ¼jّCz]9هدgڑ/َàي³ٹ»®Pت2–\ ىW2ذ~â9nخىد&صFغ^Bأ«3<ٹ9*t»ظ°o3r«‏َ{7;n‹+¯J -ڈëD›Uے¸،ث÷م•<ض پؤ’حى©Z-ا«Xœ­¸ڈHE$Zٌسآ]لشWu8U¹Sعبض<يج·»َ‎œْ‚§¾ؤK؛ئ¾×د7صê•ه^‍µ^E Yلr“ë‏ر`ش6 ITm]¶dگ لثپœkقqَUـ\›MؤقڑY؛چےںï“ؤO"üپ%B33;Wے إؤجBکـ‡$Mzn¾è3®B 3[¨ے’3f…î¶q­*مZ»lü5^¤ُھكŒTT¹,+Qx_›®¸ںHEن´\e‌>­–j ¾¼R×vCڈçUاص,„p]ë÷ڈZ®6ؤ}éƒ؛ثµ$4تSثد-Cي•_د ـHن\سm£—ذ5ü$t3ہ{çثKج6ـحسذU¼²ب³`u—n?ٌyثh€‏m‏طô|¦Zmyژ6·fِ8D[la\_زص¹÷دTTًX§ںD*Bْ†ïgص€B¢ح‡Mç±hû¸ïNضد¯B•ھٌڑo{3T(يƒ¤ںدي{£S‘ˆiْùأى•®9 ƒژه?ک<ل•¶<=Dطه©هçœn€¤ح–پ)= 1aى_â|ضٍIآ\›Wً†ّ„ïف†»Iْ½ةزF>Qü¬حآw›¬بàء®M—I—m1ہ¸›ظ“6ںü؟a¥ٹAاج\إٍ*iڈ¾ٌT~لقC §Zmi–‰دU _ْf•¾›K؛,C{”tµو[و’خھD6ُAE¹¯ض عsگڈ:‍ثb¯[عر&ٌƒâذآ‹ژ¾o8غْê؟ô4‏LœدطصXإ„ٌأ:•¸ح,ِIوك*¾ؤ¹ت¶—âےُمï¾|©ُ'³ë"0‏kf·]KLTْpRéأZے›‏U©6oب—p™ر•q=^qLGْ¸ُ6yشو_rO‡œاں~’†N¼دهklڑèud!©ـO¶dغcû¢‏Dفإrے =)—Nٍ<إ“.®c&铇sَ1„گ™Yعٌ{!iفضU9dءًْثـغ¹mPô؛è‏!5:°s‎قq®WZ½lPس`¤د°ـچٹ‰ھhأ‎D*‏ےüؤجr“ظ©ڑ«ءV1¯ù³آجثêugfù Hإüص…™ةûqقً؛ر€ا‍Kڑz‎!L}|%ژk©کàدZ^›hّ•r&°%!„k3»َ>¾â5Œ$=ڑظI!÷~{-éعƒ!#؟داGق<ےركsث¹¤_’ع–›yXsـحTT¸ة¶q‎÷½X“s3›¯ZbاC“–§سm‌ب‘»W{(bdfe‚hU‍4z<ہJjfYثàںکظ÷u×iٍsmKڈهC¯ûہ1َ/كhَ%ھ"€£÷™ھ¨‏tُهSك¾ڈـu²ƒأ?r‰“Bnfس-´E¬فMêçق.9½{ëc'×K€c,é‹÷ûQاµةü5‹ع¾Rm^چçPعe­دں§ژ¼mâژد²TزOIَm÷ïڈ~"33»j9¨HإZnK›§{؛B÷ §ض§;µ‡@nح,÷5•Véh±_‡è@OùFيپ£GïkéƒھëƒlNàµآ‌™}Vw…ي}JإD0Vëثé–B غ42üqنmQت5p(+÷›¹jsھ>كw}رق³‘^B#ں+‎.Vw ¢¼·g*–ّت$eغّb؟°ˆT„W‏£×¯QG¬ِإںµcO+•PNعEûêث+ے¾T{x#Q±قسe[ءج&*’¢m7“إھ†wھ,·ض6جى‹:تءxâB—êةé&ïپ£o-*’ôىةم»®ے°َءz«ِf.’ء´¹Tٌےط“;®T„?°†# >نعrب،ز8¶»ئü+IشکتنKےّt¢—e^mV¦µ_V–JU„.댮ŒôRر¤ïˆôz.{شً^yه8Sùj(û1}¬\ؤù’*‘ٹآmهD‏Si¸hةحlتPéD¹™‌-ù`ڑ¨X&%UQZ§؛†قµ'”†.م6„©؛×d»’/?¤bM¥´6ہ¾®0`§üا!ح|n¢œ4Oن°*&‚s®ضىد©™‌¨ّآ{r€‡کjK•?Zع¢ پŒüزف©ٌّ¸]عçهص€¯غ©°َ/j)B­–قد¤AC¸گ،طلC{}½†ِy}µ×ي9w¯îFjچA¸U}n_شd"،ِ^#P ©±ہ½¯ٹ@"ش^مَِêYw “Mگ”€u؟}Q‹سâë¨ُàXءپn ]ِ¬‍-ىF­§؟ ±B.ثE÷«ن‹Zµذà_!ـç„ُٹ¦}ژ"َH«ء؛»ن2ء ¹6W(´çَ”&غë±ـ‘{خµ(u@ئم¼¶q– لœ~~خ_(yoü-ہھّJزr°5mB+ه‹Zµ­)2WhؤI¨أںZي®~ـœàƒP$ع2V·kك°¸$X[زv,P!BCطœق[‎E-†آ`m¾®dL† /د€–mkةWNƒ±^Cَlط+-¾¾l`ف]~¬_شb¨YYdضAٍ‰°َM@ہ:¢تک§قٍ¨ïة€ &&_µپ ‌{®¬cƒ‏èw?َ†~g¨¤]–Vنْخوآ†‏fgج5}ـ=ُ=j@HجGٍضژl†§¯Aï_شb¸›oةآث,Lأ×أ•®ةر ¾طàيْ5c¸ع"AنdQhمsشKl¥ى¾¨ي،Vچ§°اsش=‘&b™gڑط‰ششبé&»’Xٌ¾ôپ…]£‏Hٌيد£V²”?}چ&uپسثِ؛َ¦e¨7ً طmسfr¨ُIU,]پ•W_`^½\ّ«jû¢[ڑع+FLN¥‰ شz0Q¤¶غ‚,I¶¢!جإءغ%ôIDAT%چï“On©ُآOXuفµ7 ئ‍3G€±7g0^"&ض‌âءٌ^7“ـتح¹bإب× wةK`1R؟¨‎5b†پü¯Zr-5é§D¢^فذ4رrه ظ#®QF Wق ظ¥ë8(.³رںŒalذےüwه²C0EAب‘ "*Hzان#ç€/›ع]©ؤ+²غ”9PŒ="ک¸…™ ك2`_ش~ئkش§`گ§‡°PcŒ،Œ6¾fµ!)v¬جOâ[”%ّ³L® ²¦ش×i2R¾¨‎ 5r› µڑ‰ث2 ضE:صألJچڑـ@چثKo}zriëء غ©5‏%ڈà‹عدPC¬‍P4¦rح„چ‌0َ‘™¨Qƒˆta•é6خN‌QO³Xےlى\گëj—_شbگل;-ظ—ب×$·€ہـqpDˆك:X’"’ي=و^&‰ز¦vٌ¯¯گاb¢p طrQnظپ‎‹?£Fآfڑ{ژˆzڑ„ش$¤à­ر¨¹[¢صگچ,:™ظع،o´Jب4ùAظ‌s1jDد©ëœY–Nفٍ©ّ؟ IVتّ8ُغQث„c2ë‹”qdـrâ>ém‰إعC‍EهپTبوغ^cٍ5 r‌0>H³ف] :،ص°:]ue†½9+*«ڈ،‚†_Cmڈع9ôIDAT´-lY^K(k;YSمAب”ë»Wأê j,XڑNâ‏B_Z´M-ق¨>M`;چْ»r¯ش;â‎bJâ‹7َZ©Li_>èWlâmqGرHˆKyئqشگ‌q¢ŒQ ‍fz™خ¶µŒî_°$fkXîزd¨‏€Qأ.إ÷¢f \ط‰¬bصض^دًZhaحطدN­{فhثP­ج7ٹ لخح†vU€³·ّ™dkئژح|ام!•‹%ة¶,طي/àjAچ>ذ¬ZDbق‹عز[{Y+ŒڑچاDY[5 N¥ھ–†€3غ.¨ڈ؛èںن‍Q}ôkMةإTـعکh ةH#8–مà$Y{?ë&هƒ››ر£ وkµ –ب[Q[Y°أ¸ …ڈ©1L£fo ·­™M`€ظ¸´}Sµأf­£=•“«وXچح¬,».*Rkآ½‚› ¨8،ï°,قٹڑ²±§e†پش0ج–Dحجm³د„¶„©fتµحzڈlم 4د&آ’a%$بM£j*g[ًRŒ ض^"ر×صQٹ&%¨‰–ذ‎چ"ص؟€ڑغ²e¤`X‡«M’Dzl[ذ¸*{mڑظtيعضسàپ[×Jى€ِvْ/’Wu7s2[ ¨¢¨ةzٍYô™ط¥¨صà.ëOک‘p·iنïGmمڈةDسغTR¨ƒ"؛Eآô©T—Vُ¦ژ{¥¹eشح~15¦ھdI6¾ڑڑJYة¬üKyي?‚;êLa¦c6ƒڑظ÷¢ µ\ˆ„ث©…ص°,ةش‘سكmùےk¼&l$ؤZ6€H؛xك±W5·K›üن*–؟ˆ¹Iuèغ‎µ5‘†€چةs\ِ¬Aچ-C¼Vآٍî‌'\‰™¥كخپF)أ¯„t;¥×¼4DI%—*›5¶GR+Pè£$y7êïض<|0•7 سèr”‹ذ=خW Pے¯Q›mjِ¯“¨9عc§ز²½ ؤخ;c®Jccژک JU1$ظ:Lژ½1…gçثQ‹% أ‏2 Iَ>ص4oىtà|”ث«ئسّ> izSg¾¬ oٌâ|ژ?L0à@}T!,L®S~ؤےWں،pû£ض{َ“شّ&ِٹî¼/é€؟fضل‏6^EY‎گlR4‡ئش<5Q>â+´ˆـnM‡-Oد[&‰ً ë1SSإ€°( ââ,¸حتdJه¼ِQشخاFtبل#¨yi(;j¨­:f_±·ٌ,Um2‌ڑى$‹Jازîفrش´9ûë¼v5ح¥ںگگ‹4$‰&ش”sGˆ^™|c¸G„ô—¯r،³‎™§„وک†¯ërbG£–ù¢–؟ژڑ){€ƒ9WôIDAT;”©رإطںAح{صxڑس‎Lqâءèبٌnأؤ¦D'ڑ¤ûœs€^ثّى‡aسœ¨OزQ÷گëہJم½ ½Fٍٍà™ڑKڈ%ءUGGôعھؤj/ا8£‰}âيnبي‹Jُ³کأü}فز‌×’Kتھ5#³~‌×Lxلثکص•_Eé_¢وآ»0إdؤ¾زm+»W ¹'%NMQOأخz+پ~•P‹‏ـض€ڑ‰÷$…€ژ„x9ھ؟ث™ںڑŒçِش¬ٹFّ–cüعWçbط†زھ>„ہï؟j´[؛» ٌ*أDة¥$^?€ڑI?¥ِ2ڑطْR›،لH«j³,خي_Sِپsƒ·؛ب÷.[رAüRيُŒù°ے@/e`Vضضˆ|R{ظظ f÷»'ک-^W®هBZ%چ~n¯¨¢مr“رƒ‏^N;G{à÷ُ¦غىûXِ‹CKôZ?³U¹²çَ&Hک ْjض‏‰:%†صVC3éZ**غ3ہC…®©«oت|^WإD\"k>>زMIA¹‍©³nٍgîWG/1è·D¹qئُہو”َO fë £œ{be›“ŒK}{M(GO ¦kژ™oٌ¤†‏خٍ%£ھק¯ ْ‎–ضùٌ†gج5bïء´ڈ fui¶$O™ôa‚ ¯طƒ+6kُ jZ¤³ک\¨f9™خح¾pômsèِ"µù¨3%éصU…ظٍm8!R¸÷ش‚‚ڈ،ô6إ»ض^±ïv%اzں<غ'”—ءNˆ¶زً÷bRص—6أ`™¥ثءFچçôڈfE™ Aُ[TK[ئ%|aه``ٍVV†ا(ں=Gk£هô9¢p—W»l§آ2jhF- 8\bP KSعگf•؛IDATُ„·ء¹ dxjهِ^غz¶(ٍه6LA"84'Bù0.gء÷£ bf‍’گ4.إ$زظ;F+Kھ;5 oف69لٹDzنT'zwآEاMع^¯ك،•^o è­ز‹طksüذعک/x5h³صآgm9Lüزˆ [ئ¾à2zSچ2eZٌⶼ?ع$ جd‏§P ¥wآك‰»dحچŒ£;VحA‹ndw}çW†¸×ذû(¥¥±ïƒk؛+g ًزرّسyA$•_f ¦‎¼¶[تŒœl¨b 9ك6qïدPَ„€دڑكm…أd  Dڑ!®©i€ùnF-ٍ>nس5ے j[R'أïmc…?Fو¼„tگôغ“z×>+§dûحAہë5ù·²jœ…K6I£ے!شvSéôزضد ¦h­Rإ?C­KG¯ئëچ ”ùع ¯ƒ§-êj£'m®¼–=غf‏§P“|cھ…/ژ1â'ùêéحM,¢:~†¢ô‰]5l5u‹|§­¥ء™²ë£G‏5ع¯ل7[è³ط0µه£-pؤ¶3Lm}¸6J•¢Fآ«ژç—ة ھL–6rهں<^sھmE-†غ\¯÷ê2 فمjےبخصtسWھe¤ژçIwً¸l€ثOجAغ-«ژ·³u@ùZNاqاjذص‚ثخszڈ`¸*“d®j؟w{ں×è èاeٹ0wv,™3xا¥l“ٌّ*کY%/؟َOي'z}/o²بڈـْمپ;أ%%GL¨ن0£g7ه‹عqâں½ƒnA~“O¯; غµ³¾ڈ3bغz*زtGaû¢vکْ'o`a+‚;ءm_شN‚pّ6تّEëü’p~­‘أD~÷ ´غ&! ¶ن›Y¾ضب»‘8ش_?¦ك™سfƒàغاüâhش‍n¶™IEND®B`‚èهˆé(€ààà Mٍّ/ب 0زص0·DTimesew Romanl©l©,ہ ô–-a0ô–ص ·DArialew Romanl©l©,ہ ô–-a0ô–ص" ·DTimes New Romanl©l©,ہ ô–-a0ô–ص0·DSymbolew Romanl©l©,ہ ô–-a0ô–ص¤€@ےے¥ .©  @£nے‎?" dd@ےےïےےےےےے  @@``€€ Œً„ًx´î¼5   &9:LKU1|~پ‚ƒ†‡گ‘’”—ک™ڑ*¥¦«®°*»½ئجخ د ض×ط ـفقكàلâمنهوç?ً„bً$؟ï<‚'يغOظZک<#ذُ®ے¥Nً$ےbً$b”u‘AZٌ ˆ•u°ضےE¥Nƒ ً0پƒ†A؟ہإAے€ٌ ـ.‰ےے™ے®ïے3™ےfے3جْ¦@ٌےےےے÷ً8َ€َ€ذ‚ے è تڑ;Tا¾9تڑ;ْg‏‎4ididèج —-a0ڑےےےpےےےpûppû@ <‎4dddd8—))0l©ہ <‎4dddd8—))0l©ہ ˆCٹh؛___PPT2001‹Dˆ<‰4Xˆد€àٹ_؛___PPT10‹? pµpµن.؛bboه.±6ٹd؛___PPT9‹F/ب 0ز®*¯h¬€ےے¯ڑ¬(€ےے €ےے ¯s¬(€ےے¯‘¬6¯›¬€ےے?ظrع% ؛^Type your title in this FOOTER area and in CAPSOظ ع=ًaxَں¨'Procurement Overview and Tender Process،(($ں¨:10th December 2008 UNICEF Supply Division Katinka Rosenbom،2;Z 7ھ,*َzVں¨Topicsھ  ں¨ةUNICEF vaccine procurement principles, objectives and process Issues pertaining to the upcoming 2010-2012 tenders for BCG, DTP, TT/DT/Td, Measles, MMR, MR, HepB, DTP-HebB, DTP-HepB/Hib, Yellow Fever.ھZ‍       َں¨=UNICEF Vaccine Procurement Principles, Objectives and Process،>i>ھ > َ[ں $Our work is still& ں¨..Guided by and committed to Vaccine Security ..Believing in a continued dialogue with industry ..Ready to change in facing new demands and situations ..Ready to take on new challenges that brings vaccines and healthy life to children ..cautious to safeguard advancements madeَں¨%UNICEF Vaccine Procurement Objectivesھ & ں¨@Vaccine Security: Ensure an uninterrupted, sustainable supply of affordable, quality vaccine Compliance to UNICEF Vaccine Procurement Principles Compliance to UNICEF Financial Rules and Regulations Compliance to Public Procurement Principles Integrity Competition Client Service Equal Treatment Organizational Objectives،0ٍ!OٍOھ ] h| َˆbں¨+Additional specific GAVI tender objectives ،,*ں¨A healthy market: ensuring the sustainable quantity of supply through a diverse supplier base Select products and presentations that best meet the need of client countries Achieving a long-term affordable price that countries can eventually finance in a sustainable manner،َŒeں¨#GAVI vaccine Procurement Principlesں NIn 2005 the GAVI Board updated the vaccine procurement principles applicable for GAVI. incorporate and expand on the UNICEF s principles Are not conflicting As a procurement agency on GAVI s behalf for a number of vaccines, UNICEF is guided by the GAVI principles for the GAVI funded vaccines.،6XFٹXFٹھ؛hَد™ں¨0General parameters of UNICEF vaccine procurement،11ں †Type: RFP for multi-year tenders; ITB for single-year tenders Duration: 1-year tender for ad hoc needs; Multi-year tenders for planned needs Invitees: WHO PQ mfrs for 1-year tenders; All interested mfrs for multi-year tenders. Process for considering manufacturers that become WHO PQ in the midst of an award remains the same. Tenders issued for specific product ranges: 2010-12 Traditional EPI Vaccines 2010-12 Hepatitis B & Hib vaccines in combination 2010-12 YF vaccine: routine, preventive campaign and stockpile 2009-2035 AMC Pneumococcal TBD Hepatitis B & Hib vaccines in combination for middle income countries 2009 -? Rotavirus Already issued: 2009-11: Separate tender: Meningitis polysaccharide vaccines Separate tender for polio vaccines: Large volumes, changing demand Ad hoc tender  specials : eg, Rabies, IPV, etc.،آyPثP: جf‏G ±-“ے3™‏Y°ھن?  H  ± -7  g     5     ¬   َچhں¨,The tender process (develop, issue, receipt)ں¨ Development of procurement strategy and objectives Demand / Forecast development Development of draft tender document with PRG* Pre-tender meeting with industry Feedback from industry and finalization of tender document Issuance of tender Clarifications Receipt of proposals (Validity) ،*!“" v£ھ  َذڑں¨)The tender process (evaluation and award)ں¨éTechnical review (by WHO) Quantitative and Qualitative review Clarification meetings with suppliers Evaluation of proposals per Evaluation Criteria & Procurement Objectives Consultation with PRG Recommendation of awards based on evaluation UNICEF internal award approval process GAVI approval, and provision, of any financial requirements Information of outcome to PRG Notification of awards to proposers Public posting of awards (www.unicef.org) Debriefing Establishment of Arrangements ،Ze³" Z…³" ZeI&ھ\Œ        َR:ںھ ں¨ژEstablishment of 3 year supply arrangements for vaccines included in these tenders Current Arrangements cover supply through 2009 Next Arrangements will cover 2010-2012 Long Term Arrangements (LTAs) Purpose: To establish forecasts between manufacturer and UNICEF on quantities to be produced and quantities to be bought over the time period; Defines Technical, Quality and Commercial requirements ،vSVئSـ.‰‏Vـ.‰‏ئھ&آ  ة َ'ں گPost-award Debriefings  What can we know about our competitor s offer? ،$I1ـ.‰‏ھ I ں nAll manufacturers are advised of the outcome of their proposal Manufacturers receiving an award are invited to a formal debriefing Manufacturers not receiving an award may request a debriefing During a debriefing session, the strengths and weakness of the manufacturer s proposal may be discussed. Details concerning the evaluation, results of a competitor will not be discussed, other than to indicate that which is publicly available.،6¸Z@E™ے‏?ô™ے‏ھ ¸ َµ‰ں¨,Ensuring equal treatment, no bias and ethics،--ں x Contracting staff are government by Financial Rules and Regulation and procedures related to ethical behaviour During tender period- communication is more formal and written, in accordance with tender instructions Bids/proposals are received and validated by an independent  Bid Section (QA) and then transferred to Contracting staff UNICEF does not accept manufacturers to fund trips, hotels, etc. or gifts Business should be conducted during normal working hours Meetings should be with min. two UNICEF staff members Suppliers not invited to UNICEF staff offices،fPœPPںPœںَ‰cں¨(Strategic Issues on the upcoming tenders،)i)ھ ) َ sں¨Three tenders for 2010-2012ھ  ں¨  Traditional EPI vaccines: DTP, TT/DT/Td, Hepatitis B, Measles, MMR, MR, BCG 2. Hepatitis B and Hib containing vaccines in combination for GAVI eligible countries 3 . Yellow Fever: routine, preventive and stockpile Issued separately, but with the same timeline. ، N“" X40MX40ھ&c  ¨ َxTںھ ں قOctober  December 2008: Review and Development Strategy Quantities / Forecast Commercial and Technical Terms and Conditions Feedback and input received from partners December 2008: Pre-tender meeting with manufacturers (10th-11th) Provide programmatic update Present tender process, terms, quantities, to manufacturers Manufacturers provide feedback Adjustments are made as necessary Mid January 2009: Tender Issuance End February 2009: Closing of Tender; target 6 weeks response time March - May, 2009: Evaluation of offers June 2009: Issuance of awards July-August 2009: Debriefings January 2010: Deliveries commence،X0ZxZAZ›ZىZx8ـ.‰‏ـ.‰‏ـ.‰‏ـ.‰‏ـ.‰‏›0   ھ p َ®~ں¨Middle Income countries (MICs)ھں Some MIC quantities are included in the EPI tender Countries were UNICEF has a history of procuring on their behalf through (Morocco and Philippines) Additional MIC forecasts received for combination vaccines. Currently being assessed Will be identified as MIC/non-GAVI eligible country demand or tendered for separately Feedback from industry on UNICEF s role in supplying MICs is welcome.،t3d<pG3d<XFھy َ،vں HCurrency of proposals  USD vs. EURO،%%ں¨†Background: UN and UNICEF accounts in USD. EURO contracts require higher degree of internal & external funds management, planning and coordination with countries to keep up with effect of currency changes. Some manufacturers have requested the possibility of quoting in EURO. UNICEF in response to requests: Proposers are required to quote in USD. If they wish Proposers may provide a quote in both USD and EURO. UNICEF will evaluate the USD FCA price or the EURO price, whatever is in the interest of UNICEF, but UNICEF reserves the right to award in USD only. For evaluation purposes the EURO offer will be converted to USD using the UN rate of exchange on the day of the closing of the bid. If a EURO offer is awarded, the resulting LTA will be in EURO throughout its duration. To be an attractive alternative for UNICEF a EURO offer must therefore be lower than the alternative USD offer،نP’-P!PMP ـ.‰‏¥G!ـ.‰‏(BWoھ(: †W pَإ•ں¨Forecasting Demand ،,iھ  َگiں¨'Forecasting: Strategic and Operational ں¨BAggregated Strategic Forecast Consolidates total expected demand, based on: Aggregated historical demand Programmatic projections Is the basis for our multiyear tendering, supply arrangements and strives to inform production planning of manufacturers Is updated annually and presented in plenary sessions with industry ،ہMZ6ZZyZZDZZ.6M  ,    E  َ·…ں¨)2009-2012 Strategic Forecast Methodology ،(*(ھ) ں ذAll countries requesting procurement of vaccines and devices through UNICEF are requested to provide a forecast that project their 5-year needs for both routine and supplemental immunization activities. Each country-driven forecast was coordinated by UNICEF country office and the National Government and was requested to be reviewed by the Interagency Coordination Committee (ICC) on Immunization. The forecast includes information on the target populations to be vaccinated, wastage rates, coverage rates, shipment plans, current stock levels, funding requirements and anticipated funding sources. Over 100 countries submitted forecasts. Forecast data is then shared and reviewed with the Global accelerated disease control programs for measles and tetanus to ensure their planning was incorporated in the forecast figures. The forecasts are reviewed in Supply Division against historic procurement, forecast accuracy, funding issues, aggregate demand The final result is a forecast that has had input from UNICEF Supply Division, UNICEF Country Offices, UNICEF Programme Division, National Governments, WHO and ICC s.،ziPتأ× a‏ُ¹× a‏™ے‏پ¦× a‏ھH0   )   َآڈں¨%Specifically for GAVI funded vaccinesں¨:Based on country forecasts and country reports, regular updates from Regional offices, GAVI applications and approval letters, long term estimations by advisors, and in the case of YF; the investment case submitted to GAVI. The forecasts have been reviewed with WHO and GAVI Secretariat as essential partners. َأگں¨bThere are a number of activities undertaken to support Strategic and Operational Forecast accuracy،ccھb ں 6 Dedicated Unit within UNICEF Supply Division focusing on Vaccine forecasting Historical Forecast Accuracy Database  enabling a comparative review of the country s forecasting ability Forecast Accuracy Reports sent to Regional and Country Offices to monitor forecast performance and encourage improvement Budgets (Provisional Plans) sent to countries, providing countries with an overview of the financial requirements for the forecasted vaccine procurement for the year ahead Reviews of the Top 20 Countries forecasted demand requirements - their demand amounts to approximately 70% of the total demand Vaccine Security Missions, on invitation to advise countries on vaccine security, the vaccine market and vaccine forecasting Program and Donor Meetings, obtaining updates on program initiatives and donor funding Continuous Forecast Updates received from Countries and Global Initiatives enabling Monthly Supplier Updates of Forecast Demand to be issued providing manufacturers with an updated overview of the calendar years forecast requirements،PP × a‏?%× a‏F× a‏`× a‏‘× a‏`× a‏d× a‏=× a‏7× a‏ھ َؤ‘ں¨Forecast Challengesں¨ءVariances in demand are due to a number of issues including: Delay or lack of Funding Independent (un-forecasted) activities Outbreaks and emergency response Political factors & in country capacity Slow uptake of new vaccines Epidemiological development Supplementary activities make up the largest volumes and have the highest variance Specific challenges for each vaccine Continuous dialogue with countries, programmes and suppliers is critical،ئ=’-أ² " ےxJ² " ے=&™ے‏#(™ے‏™ے‏S%™ے‏  ™ے‏I َ؛‹ں¨|The continuous changes in both supply and demand creates a dynamic market that requires continuous monitoring and management،}}ءU‏ھ } ں¨{Systems are in place to monitor demand against supply and to report regularly both to manufacturers, countries and partners،| |3™ے‏ھ | َز›ں¨Three tenders for 2010-2012ھ  ں¨Hepatitis B and Hib containing vaccines in combination for GAVI eligible countries Yellow Fever: routine, preventive and stockpile Traditional EPI vaccines: BCG ,DTP, DT/Td, Hepatitis B, Measles, MMR, MR, TT Issued separately, but with the same timeline. ،vش“" ZZZ0ZZش0ھ&  ُ َ;.ں¨ Thank you !،. i ھ  َب–ں¨%Overview of 2010-2012 Tender Document،&&ھ & ں¨cSome changes in the structure of the document, but any important content changes will be highlighted in the background section 5 Main Sections: 1- Purpose The objectives of the tender 2- Background Procurement Principles Forecasting Methodologies Programmatic background relevant to understand the requirement Information highlighting changes or specific points such as; scenarios for vaccines, and USD/EURO description 3- Instruction to proposers How to make and submit a proposal Information on how UNICEF will handle proposals Information on how UNICEF will debrief and share result of tender outcome. ،°‌PPPكPP‍PP’ ـ.‰‏ـ.‰‏كـ.‰‏ں  ھ&»     َة—ں¨%Overview of 2010-2012 Tender Document،&&ھ & ں¨• 4- Terms and Conditions (not exhaustive) Mandatory technical requirements WHO Technical Requirements Mandatory financial and commercial requirements, such as; UNGM registration Financial Requirements / Approval by UNICEF Supplier Evaluation Unit VVM, Shipping and Packaging Instructions, ETTMD, Vaccine Arrival Report, weight and volumes, samples Commercial Requirements; currency, MFN, Incoterm Account Management, past performance, affordable prices, monthly Allocations, Emergency response preparedness Special terms and conditions; ethical clauses General Terms and Conditions Evaluation of proposals and basis for awards Methodology, process and criteria،x*ZvZWZ}Z"Z*ـ.‰‏vW}"  ھ&„    َتکں¨%Overview of 2010-2012 Tender Document،&&ھ & ں ‚ 5- Answering sheets RFP Proposal form Qualitative Proposal sheets  for guidance Quantitative Proposal sheets  one for each vaccine, and alternative offered 2010-2012 Tender Quantities Presentation specific Requested information: Quantities, price, currency, commercial factors, lead time, packaging/weight/volume, VVM،@‹¢ـ.‰‏‹¢ھ B َھ}ں¨%Overview of 2010-2012 Tender Document،&&ھ & ں¨¦Annexes UNICEF General Terms and Conditions Shipping Guidelines VVM Specifications WHO Model Inserts UNICEF Supplier Financial Evaluation Form Vaccine Arrival Report ،*ںـ.‰‏ںھ § َ‘jںھ ں¨CUNICEF is fully funded by voluntary contributions Roughly 2/3 Governments and 1/3 Private UN Financial Rules and Regulations UNICEF to fiscal policy to be zero risk UNICEF cannot make external financial commitment without having internal committed commensurate funding Funding and Budgetary Cycles of vaccines Over 500 funding streams for vaccine procurement each year Normally arrives 4-12 weeks prior to delivery Funding changes from year-to-year (one donor is not Government budgets are annual and subject to their release cycles Working on behalf of the poorest countries،ہ2)$’);.،2ـ.‰‏)#ـ.‰‏’)ـ.‰‏; .     ھ D َڑpں jWhy not  conditional awards for non-WHO PQ products?،66ھ5 َwRں¨Proposals from Manufacturers،ھ ں¨VManufacturers are invited to submit a comprehensive proposal Responsive to projected quantities for each product presentation The type of vaccine being proposed, and specifications Unit price per vial and per dose Annual and monthly production for first year Alternative vaccine presentations/products Comply with all MANDATORY REQUIREMENTS Comply with the INSTRUCTIONS TO PROPOSERS and information requested there within Provide explanations to any request for exceptions or clarification on the RFP PROPOSAL FORM UNICEF and WHO will review the proposal and hold discussions with manufacturers ،ژ>A±’" xHذے^Q<ـ.‰‏j]Q  ـ.‰‏ھV َ{Wں¨Proposal Evaluation Process،ھ ں¨×Review of Mandatory Requirements WHO Pre-qualification Financial Review by UNICEF Supplier Evaluation Unit (SEU) Compliance to UNICEF General Terms and Conditions Quantitative Review of Proposal Products offered, quantities, price, delivery schedule, lead-times, ability to maintain buffer stock, shelf life, VVM Qualitative Review of Proposal Proven experience and past performance Ability to perform account management / good communication On-time delivery performance ،€!‚ v€!ـ.‰‏‚ ـ.‰‏vـ.‰‏€ ھ× َ|Xں¨Technical Review of Proposals،ھ ں¨OAll proposals are reviewed by WHO Key areas that WHO review are: compliance to mandatory technical requirements compliance to preferred technical requirements for products not WHO pre-qualified at time of offer, WHO conducted an assessment of timeline given for pre-qualification other technical issues (Regulatory oversight, etc..) ،dC "ـ.‰‏ـ.‰‏ ھO َ£xں¨Public Notification of Awards،ں¨زUNICEF has standard procedures for publication of awards on website: Tender, duration, total value, material(s), supplier name This is UNICEF standard procedure (not just immunization) To meet request for information sharing, all Proposers will receive, after awards are made a letter including the following information: Total vaccine quantity awarded per year per presentation at an aggregate level Number of suppliers awarded per year per vaccine presentation Yearly awarded weighted average price (WAP) per vaccine presentation Total contract value awarded to each supplier, with listing of included vaccines. Annual awarded weighted average price for each vaccine presentation will be posted on the UNICEF web-site.،ٹEu‰$lEـ.‰‏sـ.‰‏‰ـ.‰‏$kـ.‰‏ھZ< (   L 6 vl /ًPََ< َ‚ َٹَڈَ›َءَاَثَجَحَرêّBï 0`ً ےےے€€€»àم33™™™™ج`ً ےےے–––ûكSے™fج3™f`ً ےےے€€€™جےججے33ج¯gے`ً قٌِ–––ےےےچئےfج¨`ً ےےظwwwےے÷3ججےPPے™`ً €€ےےےZXےے™dbmoاےےے`ً €ےےے\كز“q>9¾y`ےے™س¢`ً ™ےےے3fجےے3fج°fجےےç`ً ےےے3f™مëٌ3™FٹKfجےًه`ً hk]ےےےwwwررثگگ‚€‍¨ےجféـ¹`ً ff™ےےے>>\ےےے`Y{ffے™جےےے™`ً R>&ےےے- كہچŒ{pڈ_/ج´Œ‍ £>ے‎?" dd@ےےïےےےےےے™ے‏£tے‎?" ddp@ےےïےےےےےے!گ¸ذ@ً`€ £nے‎?" dd@ےےïےےےےےے   @@``€€P£N ¸ @ ` €`£(p£H¸@`€€£H¸@`€ ®ً¦ًًDً( ً ًًà ً “ ً6€„g ‡پƒ؟ہے "ٌ؟ًًپ،—ًأ   ًTں¨ CLICK TO EDIT MASTER TITLE STYLE¢!ھ !ً$ ً ƒ ً0€L پƒ؟ہے "ٌ؟ً°ذ´ًأ   ً‍ں¨RClick to Edit Master Text Styles Second level Third level Fourth level Fifth level¢!    ھ SًB ً s ً*پ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™ج ؛New BrandîGï €0 ÷ًï ً ًچً( ً„@ R@ ًًà ً “ ً6€xç ‡پƒ؟ہے "ٌ؟ً @ہP ًأ   ًTں¨ CLICK TO EDIT MASTER TITLE STYLE¢!ھ !ًف ً ƒ ً0€™[ پƒ؟ہے "ٌ؟ًً@ہگ ًأ   ًWں¨#CLICK TO EDIT MASTER SUBTITLE STYLE¢$ھ $ًˆ² ً  C ًR€€Aء:Unitepluslogo_Eng_White copy"ٌ؟ً0pہGًB ً s ً*پ™ے“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جً ٌ€0 ٹً‚0ً(ًً( ً ً(ًج ً( ƒ ً0€à¦پƒ؟ہے ًP%ًأ   ًTں *، ùھ ًخ ً( ƒ ً0€ـ پƒ؟ہے ًگ à%ًأ  ًVں *، ّھ ًd ً( c ً$‡؟ے ?ً·¸(K ًأ ً ً( ƒ ً0€@›پƒ؟ہے ًق @ )ًأ  ً‍ں¨RClick to edit Master text styles Second level Third level Fourth level Fifth level¢!    ھ Sًز ً( “ ً6€°هœ‡پƒ؟ہے ً»Pàًأ   ًTں *، ْھ ًش ً( “ ً6€p꜇پƒ؟ہے ً»گ ààًأ œ ًVں *، طھ ًH ً( ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.جïآ Hˆ ة€ ًہً<ً ً( ً ً<ًذ ً< ƒ ً0€0‡غ پƒ؟ہے ًP%ًأ  غ  ًXں *، ùھًز ً< ƒ ً0€بپغ پƒ؟ہے ًڈ ك%ًأ غ  ًZں *، ّھًض ً< “ ً6€¨€غ ‡پƒ؟ہے ً؛Pكًأ  غ  ًXں *، ْھًط ً< “ ً6€HXo‡پƒ؟ہے ً؛ڈ ككًأ غ  ًZں *، طھًH ً< ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€»àم33™™™™جˆ8ٹ0؛___PPT10‹ë.ثےإگ×9îaï€0 ˆً€@ًًً( ً‍w ًًl ً C ً€ŒP ؟ےًً@ہ ًأ   ً ‍ًl ً C ً€´›[ ؟ےًP @ہً ًأ [  ً ‍ًH ً ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆپٹy؛___PPT10‹Y+Dٌ='ٌ ےےےے=ٌ @Bٌ +î$ï €0 ”ًŒًً$ً( ً ًًr ً S ً€ذ» ؟ےًًپ،—ًأ    ً ‍ًr ً S ً€,± ؟ےًصذظًأ   ً ‍ًH ً ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ8ٹ0؛___PPT10‹ë.Hئp¹îéï €0 ً0ً\ً ً( ً ً\ًR ً\ s ً*…‡پ™ے؟ہےً€àً~ ً\ s ً*€,³ ‡؟ےˆًj¯ىخ ًأ    ً ‍ًˆ² ً\ C ًR€€Aء:Unitepluslogo_Eng_White copy"ٌ؟ً0pہGًH ً\ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆپٹy؛___PPT10‹Y+Dٌ='ٌ ےےےے=ٌ @Bٌ +îّï € 0 hً``ً(ًًّ( ً ً(ًr ً( S ً€Hء ؟ےًًپ،—ًأ    ً ‍ًr ً( S ً€ آ ؟ےً/ذ3ًأ   ً ‍ًج ً( “ ً6€¨أ ‡پƒ؟ہے ًد ‍‡v ًfں 6& to better children s lives،ًH ً( ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ8ٹ0؛___PPT10‹ë.sXة@تgjîةï €0 ًًè`ًhً€ً( ً ًhً~ ًh s ً*€0ج ؟ےˆًز،ءإًأ    ً ‍ًآ ًh ƒ ً0€¨ز €پےے™؟ےˆًگ‍ًًً<$ٌ0أ   ً‍¦ طش ًH ًh ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ ےےےے=ٌ @Bٌ +î:ï €0 ھً¢ ًPً:ً( ً ًPًr ًP S ً€” ؟ےًًپ،—ًأ    ً ‍ًˆ ًP S ً€" ؟ےً§ـœ«ًأ   ً"‍¦ّ ¨0PpًH ًP ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ8ٹ0؛___PPT10‹ë.Yة`‍bî$ï €0 ”ًŒ@ ً`ً$ً( ً ً`ًr ً` S ً€0% ؟ےًًپ،—ًأ    ً ‍ًr ً` S ً€+ ؟ےًzـœ~ًأ   ً ‍ًH ً` ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ8ٹ0؛___PPT10‹ë.Yة0;Dî$ï €0 ”ًŒ@ً ً$ً( ً ً ًr ً  S ً€0 ؟ےًًپ،—ًأ    ً ‍ًr ً  S ً€ج0 ؟ےًMـœYًأ   ً ‍ًH ً  ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ8ٹ0؛___PPT10‹ë.Zة€ˆt`î«ï €0 آً؛p ًlًRً( ً ًlًx ًl c ً$€E ؟ےˆًïے `؟ًأ    ً ‍ًگ ًl c ً$€|K ؟ےˆًjجâ ًأ   ً$‍¦ّ8 0Ppً¢ ًl ƒ ً0€¬N ؟پƒ؟ہےً´ج´t ً¢ں¨N*PRG: Procurement Reference Group established for some GAVI supported vaccines،O 2OھN ًH ًl ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ‘ٹ‰؛___PPT10‹ië._ںئ@–ڑ³+Dٌ='ٌ ےےےے=ٌ @Bٌ +î«ï €0 آً؛Pً¬ًRً( ً ً¬ًx ً¬ c ً$€H{[ ؟ےˆًïے `؟ًأ  [  ً ‍ًگ ً¬ c ً$€ّY ؟ےˆًجâf ًأ [  ً$‍¦ّ8 0Ppً¢ ً¬ ƒ ً0€¤b ؟پƒ؟ہےً´ج´t ً¢ں¨N*PRG: Procurement Reference Group established for some GAVI supported vaccines،O 2OھN ًH ً¬ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ‘ٹ‰؛___PPT10‹ië._ںئ@–ڑ³+Dٌ='ٌ ےےےے=ٌ @Bٌ +înï €0 ’ًٹPًdً"ً( ً ًdً¼ ًd s ً*€ذ“ ؟ےˆً0PpP ً<$ٌ0أ   ً‍¦ طش ً& ًd س ًN€„0[ ‡؟?پƒ؟ ہے?“"ٌ6?@؟`ےہ؟‚‚N؟NےN?Nًً'G— ًjں¨The expected tender outcome ،ھ  ًH ًd ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆ„ ٹ| ؛___PPT10‹\ ê.+خàEADٌü 'ٌ ےےےے=ٌ @Bٌ Dٌ· 'ٌ •ےےےے=ٌ @BٌAٌ?%ٌ,(ٌ <ٌ +O%ٌ,(ٌ <ٌ +Dٌs'ٌ =ٌ%ٌ(ٌےےےےDٌ'ٌ =ٌ%ٌ(ٌDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*dS%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*dS‚%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*d‚©%ٌ(ٌَDٌs'ٌ =ٌ%ٌ(ٌےےےےDٌ'ٌ =ٌ%ٌ(ٌDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*dھب%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*dبW%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*dWژ%ٌ(ٌَ+8+0+d0 +î؟ ï €0 وًق`ً¨ًvً( ً ً¨ً¦ ً¨  ًF€¤ں پ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےًز¯دًٍأ    ً ‍ًگ ً¨ s ً*€„© ؟ےˆً§¯og ًأ   ً‍¦ طش ًH ً¨ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ ےےےے=ٌ @Bٌ +î¹ï €0ù^N0 ¸ً°ہ ً@ًHً( ً ً@ً~ ً@ s ً*€„ ؟ےˆًïےùًأ    ً ‍ًٹ ً@ c ً$€€ ؟ےˆًإہگ) ًأ   ً‍¦ طش ًH ً@ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ‘ّ€€€ج™33جججے²²²ˆ‘ٹ‰؛___PPT10‹ië.âإ“v…+Dٌ='ٌ ےےےے=ٌ @Bٌ +î3ï €0 ZًR ًTًêً( ً ًTًR ًT s ً*…‡پ™ے؟ہےً€àً~ ًT s ً*€8 ‡؟ےˆًj¯´خ ًأ    ً ‍ًB² ًT C ً€€Aءً¬`ہ4ًˆ² ًT C ًR€€Aء:Unitepluslogo_Eng_White copy"ٌ؟ً0pہGًH ًT ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆپٹy؛___PPT10‹Y+Dٌ='ٌ ےےےے=ٌ @Bٌ +îإ ï €0 ىًن° ً¼ً|ً( ً ً¼ً¦ ً¼  ًF€ پ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےً‡ù.ًأ    ً ‍ً– ً¼ s ً*€lO؛؟ےˆً¨‍YIًأ   ً$‍¦ًّ 0PpًH ً¼ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ ےےےے=ٌ @Bٌ +îےï €0 &ًàًً¶ً( ً ًًٹ ً c ً$€ش ؟ےˆًٍùص"ًأ [  ً‍¦ طش ًى ً س ًN€¨®[ ‡؟?پƒ؟ ہے?“"ٌ6?@؟`ےہ؟‚‚N؟NےN?Nًً'G— ً0ں¨Timelineھ  ًH ً ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ ےےےے=ٌ @Bٌ +î0ï €0  ًکذ ًً0ً( ً ًًx ً c ً$€h°[ ؟ےˆًًپ،—ًأ  [  ً ‍ًx ً c ً$€l"[ ؟ےˆًMپے,ًأ [  ً ‍ًH ً ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ8ٹ0؛___PPT10‹ë.Yة°ڈ¦nî0ï €0  ًکà ًبً0ً( ً ًبًx ًب c ً$€€\[ ؟ےˆً•'G<ًأ  [  ً ‍ًx ًب c ً$€(][ ؟ےˆً½ùY†ًأ [  ً ‍ًH ًب ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ8ٹ0؛___PPT10‹ë.-Yةً{™]îéï €0 ًہ ً€ً ً( ً ً€ًR ً€ s ً*…‡پ™ے؟ہےً€àً~ ً€ s ً*€ ظ[ ‡؟ےˆًj¯´خ ًأ  [  ً ‍ًˆ² ً€ C ًR€€Aء:Unitepluslogo_Eng_White copy"ٌ؟ً0pہGًH ً€ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆپٹy؛___PPT10‹Y+Dٌ='ٌ ےےےے=ٌ @Bٌ +î’ï €0 ©ً،گ ًtً9ً( ً ًtً~ ًt s ً*€¬ة[ ؟ےˆًًپ،—ًأ  [  ً ‍ً¸ ًt ³ ًB€ü3 ‚„؟ہآےےےؤے ˆ"ٌ؟`ًصù? • ًأ [  ً ‍¦ èط8Xً» ًt ƒ ً0€ £[ پƒ؟ہے "ٌ؟`ًصœ â•  ًMں¨ةOperational Forecast Based on actual country uptake Guides our day-to-day supply and demand matching and management, and informs suppliers production scheduling Is updated monthly to LTA holders،hZZ´Zg)#ًH ًt ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ‘ٹ‰؛___PPT10‹ië.بBةہP8+Dٌ='ٌ ےےےے=ٌ @Bٌ +î‰ï €0  ًک` ً(ً0ً( ً ً(ًx ً( c ً$€XG ؟ےˆً¤ùًٍأ    ً ‍ًx ً( c ً$€0H ؟ےˆًضج‡<ًأ   ً ‍ًH ً( ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ‘ٹ‰؛___PPT10‹ië.y‏إ`ow+Dٌ='ٌ ےےےے=ٌ @Bٌ +î$ï €0 ”ًŒ` ًhً$ً( ً ًhًr ًh S ً€بW ؟ےًًپ،—ًأ    ً ‍ًr ًh S ً€|^ ؟ےً§ـœ«ًأ   ً ‍ًH ًh ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ8ٹ0؛___PPT10‹ë.ٌ+Bٌ#style.visibility<ٌû*pےےےےےےےے%ٌ(ٌ+8+0+p0 +îشï €0 0ً(à ًHًہ ً( ً ًHً~ ًH s ً*€Xٹ ؟ےˆًٍù"ًأ    ً ‍ًً ًH  ًF€ذگ پ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءآےےےأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےًDùZ) ً<$ٌ0أ   ً*‍¦ًّ§ ًH “ ً6€گ‘؟ ‡پƒ؟ہے ًâ€0 ًAں¨Supply Managementھ ًR ًH س ًN€(” ‡؟?پƒ؟ ہے?“"ٌ6?@؟`ےہ؟‚‚N؟NےN?Nً"¯‎؛ ً–ں¨N~ 40 Vaccines from ~ 16 Suppliers ~ 14 Immunization devices from ~ 8 Suppliers،OOھ O ًX‚ ًH ƒ ً0…‡پƒ؟ہےً"پ®èً ًH س ًN€ؤ€؟ ‡؟?پƒ؟ ہے?“"ٌ6?@؟`ےہ؟‚‚N؟NےN?Nًُغ‏چ ًXں¨80-100 countries،ھ  ً…¢ ًH ƒ ً0€œ– ؟پƒ؟ہےًڑ ù%ً,$ٌ0 ًٌں¨ںUNICEF has the capacity to reallocate demand and supply between Countries and Suppliers, to avert crisis and reduce the impact of demand or supply fluctuations،  ءU‏ھں ًH ًH ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆLٹD؛___PPT10‹$+)9‘÷Dٌک'ٌ ےےےے=ٌ @Bٌ DٌS'ٌ •ےےےے=ٌ @BٌAٌ?%ٌ,(ٌ <ٌ +O%ٌ,(ٌ <ٌ +DٌA'ٌ =ٌ%ٌ(ٌےےےےDٌé'ٌ =ٌ%ٌ(ٌDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*H|%ٌ(ٌDٌA'ٌ =ٌ%ٌ(ٌےےےےDٌé'ٌ =ٌ%ٌ(ٌDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*Hےےےےےےےے%ٌ(ٌ+p+0+H0 ++0+H0 +îإ ï €0 ىًنpً´ً|ً( ً ً´ً¦ ً´  ًF€ہض[ پ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےًزùyًأ  [  ً ‍ً– ً´ s ً*€¤¢ ؟ےˆً¨‍YIًأ [  ً$‍¦ًّ 0PpًH ً´ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ ےےےے=ٌ @Bٌ +îéï € 0 ًگًôً ً( ً ًôًR ًô s ً*…‡پ™ے؟ہےً€àً~ ًô s ً*€üœ[ ‡؟ےˆً¯´ًّأ  [  ً ‍ًˆ² ًô C ًR€€Aء:Unitepluslogo_Eng_White copy"ٌ؟ً0pہGًH ًô ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆپٹy؛___PPT10‹Y+Dٌ='ٌ ےےےے=ٌ @Bٌ +î؟ ï €0 وًقà ًˆًvً( ً ًˆً¦ ًˆ  ًF€ذè[ پ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےًً'G—ًأ  [  ً ‍ًگ ًˆ s ً*€P¾ ؟ےˆًإ‍Y‏ًأ [  ً‍¦ طش ًH ًˆ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ ےےےے=ٌ @Bٌ +î؟ ï €0 وًقًگًvً( ً ًگً¦ ًگ  ًF€ہ[ پ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےًً'G—ًأ  [  ً ‍ًگ ًگ s ً*€¤$ف؟ےˆًإ‍Y‏ًأ [  ً‍¦ طش ًH ًگ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ ےےےے=ٌ @Bٌ +î؟ ï €0 وًق ًکًvً( ً ًکً¦ ًک  ًF€P3[ پ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےًً'G—ًأ  [  ً ‍ًگ ًک s ً*€Eف؟ےˆًإ‍Y‏ًأ [  ً‍¦ طش ًH ًک ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ ےےےے=ٌ @Bٌ +îف ï €0  ًü° ًüً”ً( ً ًüًگ ًü s ً*€ّ)ف؟ےˆًإ‍´†ًأ [  ً‍¦ طش ًؤ ًü C ًX€ ¥؟ پ0e‚ک²ƒ0e„ک²…†‡ˆ‰ٹ‹؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?A¨)BCD|¾E„|¾…†|¾‡ˆƒ "ٌŒچ0eےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےًًپ،—ًأ  ؟  ً ‍ًH ًü ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ ےےےے=ٌ @Bٌ +î:ï €0 ±ً©  ًxًAً( ً ًxً¼ ًx s ً*€ذBف؟ےˆً0PâP ً<$ٌ0أ [  ً‍¦ طش ًE ًx س ًN€´¹؟ ‡؟?پƒ؟ ہے?“"ٌ6?@؟`ےہ؟‚‚N؟NےN?Nًً'G— ً‰ں¨CWhy are they arrangements for what is forecasted and not more firm?،DDھ D ًH ًx ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆ1ٹ)؛___PPT10‹ ê.+خàEADٌ©'ٌ ےےےے=ٌ @Bٌ Dٌd'ٌ •ےےےے=ٌ @BٌAٌ?%ٌ,(ٌ <ٌ +O%ٌ,(ٌ <ٌ +Dٌع'ٌ =ٌ%ٌ(ٌےےےےDٌ‚'ٌ =ٌ%ٌ(ٌDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*x2%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*x2[%ٌ(ٌَDٌs'ٌ =ٌ%ٌ(ٌےےےےDٌ'ٌ =ٌ%ٌ(ٌDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*x\%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*x§%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*x§%ٌ(ٌَDٌ> 'ٌ =ٌ%ٌ(ٌےےےےDٌو 'ٌ =ٌ%ٌ(ٌDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*x:%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*x:u%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*xu£%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*x£×%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*x×%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*xD%ٌ(ٌَ+8+0+x0 +î«ï €0 زًتP ً¤ًbً( ً ً¤ً¤ ً¤ s ً*€طfف؟ےˆًMùگ,ًأ [  ً2ں ”UNICEF attempted this in 2001-2003 period Experience: We were not good at  picking winner None of conditional award timelines were met (projected time for WHO PQ and production start-up) Several were not met even during the 3-year period Change in approach: We no longer issue conditional awards When a manufacturer product becomes WHO PQ, then award process is initiated (if applicable) Let competitive process determine the  winner (in terms of timing)،l7؛ئ*جf‏ جf‏؛جf‏ئ¦ّ8¨0Ppً~ ً¤ s ً*€ـRف؟ےˆًwù¦ًأ  ف ً ‍ًH ً¤ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ [ ےےےے=ٌ @Bٌ +î‰ï €0  ًکہًً0ً( ً ًًx ً c ً$€Xrف؟ےˆًw'Gًٌأ  ف ً ‍ًx ً c ً$€sف؟ےˆً<T,ًأ ف ً ‍ًH ً ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ‘ٹ‰؛___PPT10‹ië.ےإ° ٹg+Dٌ='ٌ [ ےےےے=ٌ @Bٌ +î‰ï €0  ًک ًً0ً( ً ًًx ً c ً$€X‚ف؟ےˆًw'Gًٌأ  ف ً ‍ًx ً c ً$€0ƒف؟ےˆً<Tvًأ ف ً ‍ًH ً ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ‘ٹ‰؛___PPT10‹ië.ےإ° ٹg+Dٌ='ٌ [ ےےےے=ٌ @Bٌ +î‰ï €0  ًک0ًً0ً( ً ًًx ً c ً$€X[ف؟ےˆًw'Gًٌأ  ف ً ‍ًx ً c ً$€\ف؟ےˆً<Tvًأ ف ً ‍ًH ً ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ‘ٹ‰؛___PPT10‹ië.ےإ° ٹg+Dٌ='ٌ [ ےےےے=ٌ @Bٌ +î‰ï €0  ًک ًذً0ً( ً ًذًx ًذ c ً$€ٹف؟ےˆً'G–ًأ  [  ً ‍ًx ًذ c ً$€èٹف؟ےˆًâù‡ؤًأ ف ً ‍ًH ًذ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ‘ٹ‰؛___PPT10‹ië.ےإ° ٹg+Dٌ='ٌ [ ےےےے=ٌ @Bٌ +ً(ٌ0 ¨ً @ً`ً8ً( ً ً`ًd ً` c ً$؟ے(ˆً·¸(K ًأ  غ ً” ً` s ً*€”xغ ؟ے(ˆًق @ )ًأ  غ  ً"ںھ ًH ً` ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.ِ0أPg8—ً(ٌ.0 ¨ً  ًًّ8ً( ً ًًّd ًّ c ً$؟ے(ˆً·¸(K ًأ  غ ً” ًّ s ً*€4~غ ؟ے(ˆًق @ )ًأ  غ  ً"ںھ ًH ًّ ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.ِ0أPg8—ًٹ ٌ[0  ً pً,ًڑً( ً ً,ًX ً, C ً؟ے(ً·¸(K ًأ  غ ً ً, S ً€èطغ ؟ے(ًق @ )ًأ  غ  ًœں 8Comments: Although the means and focus to achieving this may differ for different vaccines and depending on what characterizes the specific markets. Industry and other stakeholders will continue to inform our behaviour, and we welcome your presence here and in in other fora for interaction. Some of the positive changes we can proudly (you and us) recon ourselves as causing or contributing to; such as the advancing use of new vaccines in the developing world and the changes this causes in the market characteristics  both supply and demand. Other positive momentums are championed by others, but if we believe they have the capacity to advance children s lives positively  such as the AMC mechanism - we will support, contribute and take on the challenge of making it work. We will not risk loosing the Vaccine Security gains we have made, so we will not make fickle changes, or make random changes in strategy. ،‌Z‌ھ,dًH ً, ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.sXةہڈ<ًُ(ٌc0 ¨ً  ًXً8ً( ً ًXًd ًX c ً$؟ے(ˆً·¸(K ًأ  غ ً” ًX s ً*€X“غ ؟ے(ˆًق @ )ًأ  غ  ً"ںھ ًH ًX ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.ِ0أPg8—ً ٌh0 Œً„€ ًpًً( ً ًpًX ًp C ً؟ے(ً·¸(K ًأ  غ ً„ ًp S ً€ôکغ ؟ے(ًق @ )ًأ  غ  ًںھ ًH ًp ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.Yة0‏vًèٌp0 ¨ً ` ً¨ً8ً( ً ً¨ًd ً¨ c ً$؟ے(ˆً·¸(K ًأ  غ ً” ً¨ s ً*€گ‍غ ؟ے(ˆًق @ )ًأ  غ  ً"ںھ ًH ً¨ ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ً@ٌ‹0 ہً¸ً ًLًPً( ً ًLًd ًL c ً$؟ے(ˆًآء:] ًأ  غ ً¬ ًL s ً*€¤غ ؟ے(ˆًم P¨?ًأ  غ  ً:ں،Zھ ًH ًL ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.ں%ئ أ¶ً(ٌ•0 ¨ً ذ ً„ً8ً( ً ً„ًd ً„ c ً$؟ے(ˆً·¸(K ًأ  غ ً” ً„ s ً*€p°غ ؟ے(ˆًق @ )ًأ  غ  ً"ںھ ًH ً„ ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.ِ0أPg8—ًاٌ–0 Gً?ً ًŒً×ً( ً ًŒً^ ًŒ S ً؟ے(ˆً·¸(K ًأ  غ ً9 ًŒ c ً$€4¶غ ؟ے(ˆًق @ )ًأ  غ  ًحں¨sInstruction to proposers: Incoterms, errors, validity, registration, country of origin, samples, debriefings etc. ھ>  >ًH ًŒ ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.Yةًûھ‍ًاٌ—0 Gً?ً”ً×ً( ً ً”ً^ ً” S ً؟ے(ˆً·¸(K ًأ  غ ً9 ً” c ً$€ـ؟غ ؟ے(ˆًق @ )ًأ  غ  ًحں¨sInstruction to proposers: Incoterms, errors, validity, registration, country of origin, samples, debriefings etc. ھ>  >ًH ً” ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.Yةًûھ‍ًاٌک0 Gً?0ًœً×ً( ً ًœً^ ًœ S ً؟ے(ˆً·¸(K ًأ  غ ً9 ًœ c ً$€\ةغ ؟ے(ˆًق @ )ًأ  غ  ًحں¨sInstruction to proposers: Incoterms, errors, validity, registration, country of origin, samples, debriefings etc. ھ>  >ًH ًœ ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.Yةًûھ‍ًٌڑ0 کًگ`ً°ً(ً( ً ً°ً^ ً° S ً؟ے(ˆً·¸(K ًأ  غ ًٹ ً° c ً$€8sغ ؟ے(ˆًق @ )ًأ  غ  ًںھ ًH ً° ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.Yة0‏vrH يˆ 7گ ‍ †“µ¢¦¨مq'يب; tMک™Rw¹w ںg}âz0‰ 0jءl¦¥‚Cvˆ0w«uصصŒ ¹­²ڈ0‚هىھHڑ ى`„  °ط¼ç£Roھإ>®„هµ´ز·ٌ؛ضےءP †ô<ِحّôéاpQˆp!7+‏4پٹPچگد@ه¯ؤµî’²ُ®•زإ1‏ےà…ںٍùOh«‘+'³ظ0جT hp” ´ ؤذ ً ü نCLICK AND TYPE TITLE HERErdm New Brandkdorgan90Microsoft PowerPoint@à¨÷6ق@€Hô‏إ@ {lg\ة/ G¨Sےےےے‰g  ج)،'  رء ÷€€€€€€€€€ہہہہـہ¦تً """)))UUUMMMBBB999ے|€ےPPض“جىےïضئççض­©گ3f™ج333f3™3ج3ے3f3fff™fجfےf™3™f™™™ج™ے™ج3جfج™جججےجfے™ےجے333f3™3ج3ے333333f33™33ج33ے33f33f3ff3™f3جf3ےf3™33™3f™3™™3ج™3ے™3ج33ج3fج3™ج3جج3ےج33ے3fے3™ے3جے3ےے3f3fff™fجfےf3f33ff3f™3fج3fے3fff3fffff™ffجff™f3™ff™f™™fج™fے™fجf3جf™جfججfےجfےf3ےf™ےfجےfےججے™™™3™™™ج™™33™f™ج3™ے™f™3f™f3™™f™جf™ے3™3™™f™™™™™ج™™ے™™ج™3ج™fجf™ج™جج™ےج™ے™3ے™fج™™ے™جے™ےے™ج3™fج™ججج3™33جf3ج™3جج3جے3جfج3fجff™™fججfجےf™™ج3™جf™ج™™جج™جے™ججج3ججfجج™جججججےججےج3ےجfے™™ےججےجےےج3جfے™ے3ج33ےf3ے™3ےج3ےے3ےfے3fےffج™fےجfےےfج™ے3™ےf™ے™™ےج™ےے™ےجے3جےfجے™جےججےےجے3ےےfےج™ےےجےےےfffےfےےfffےےfےfےے¥!___www†††–––ثثث²²²×××فففمممêêêٌٌٌّّّےûً  ¤€€€ےےےےےےےےےےccً2"4،'A جx ذہ( xK€€€€€€€€€ہہہہـہًت¦ """)))UUUMMMBBB999€|ےPPے“ضےىجئضïضççگ©­3f™ج3333f3™3ج3ےff3fff™fجfے™™3™f™™™ج™ےجج3جfج™جججےےfے™ےج3333f3™3ج3ے3333333f33™33ج33ے3f3f33ff3f™3fج3fے3™3™33™f3™™3™ج3™ے3ج3ج33جf3ج™3جج3جے3ے33ےf3ے™3ےج3ےےff3fff™fجfےf3f33f3ff3™f3جf3ےffff3fffff™ffجf™f™3f™ff™™f™جf™ےfجfج3fج™fججfجےfےfے3fے™fےججےےج™™™3™™™™ج™™33™f™3ج™ے™f™f3™3f™f™™fج™3ے™™3™™f™™™™™ج™™ے™ج™ج3fجf™ج™™جج™جے™ے™ے3™جf™ے™™ےج™ےےج™3جfج™جج™3ج33ج3fج3™ج3جج3ےجfجf3™ffجf™جfج™fےج™ج™3ج™fج™™ج™جج™ےجججج3ججfجج™جججججےجےجے3™ےfجے™جےججےےج3ےfے™ج3ے33ے3fے3™ے3جے3ےےfےf3جffےf™ےfججfےے™ے™3ے™fے™™ے™جے™ےےجےج3ےجfےج™ےججےجےےے3جےfےے™ےےجffےfےffےےےffےfےےےf!¥___www†††–––ثثث²²²×××فففمممêêêًٌٌٌّّّûے¤  €€€ےےےےےےےےےےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسشسسسسسشسسسشسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسشعسسسسسسسشسسششسسشعسسسسسسسعشعسسسسسسسسسسسسسسسسسسسسسسسسسسـشغشـغـعـشغغـشغسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسشâغâغلشسـغـعـــعـــغشلسسشلــغâغسسسسسسسسسسسسسسسسسسسسسسسسغغصغغـغغــصـغغشسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسـصســـعسـصفغـسعغâسششغـسســــےصـشسسسسسسسسسسسسسسسسسسسسسسسعشغشعغعشغسشسعشسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسـغسـغلشسـغـلغسسغâــâعلسعـâـغââـلسسسسسسسسسسسسسسسسسسسسسسسسشسسسشسششسسسسشسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسـغسغـــسâشâشـسـشفشغـغـششـâـشےےــسسسسسسسسسسسسسسسسسسسسسسسـغلشغغغغغسغغغغغسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسشغسغشغغلغعغسغلغسشلـعـâشعغلےــâغـسسسسسسسسسسسسسسسسسسسسسسسغغغغغغغغغششغصغغشسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسغسسسسسسسسسعـسسغشےغغشعشسسسسسسسسسسسسسسسسسسسسسسسعسسسعععسعسغغعسشسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسعـعسسسسسسسسسلـعسسشلـعسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےسےےےےےسےےسےےسےسےسےےےےےےسےسےےسےےسےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےسےےےےےےےسسےےسےےسسےےےسےےسےےےےسےےسےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےسسسےےسسےسسسسسےےسسسسسسسسسسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسےسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےسےسےےےےےےسسسےسسےےسےےسےےےےےےسسسےےسےسسےےےےسےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسےےےےےےسسےےسسےےسسےسےسسےےےےےےےسسےسےےےےےےسےسےےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسےےسےےےےسےسسسےسسےےسسسسسسسسےسسسسےےسےسسےسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےسسسسےےسےےےےسےےسےےسےےسےےےسسےسےےسےےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسےےےےسسےسےےےےےسےےسےےےےےسےےےسسسےےےسےےسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےےسسسےےسسسسسسسسسسسسےسسسسسسسےےےےسےےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسسسےسسےےسسےےسسےےسےےسسےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسسسےسےسسےےسسےےسسسےسےسےسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےےسسےسےسسےےسسسےےےسسےسسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسےسسےسےسسےےسسےےسےسےےسسےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسےسسےےسےےسسےےسسےسسسےےسسےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسسسےسسےےسسےےسسسےسسےسسےےسسےسےسےسسےےسسسےےسسےےسسےےےسسسےےےسسےےسسےسےےےسےسسےےسسےسےسسسسےےےےسےےسسسےےےسسسسےسسسےےسسسےےسسےےےسسےےسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسسسےسےسسےےسسےسےےسسےسےسسسسےسےسےسےسسسسسےےسسےسسےسسسےسسےسےسےسسسسےسےسےسےسےسسسےےےسےسسسےسسےسےےسسےسسےسسسسےسسےسسسسسےےسےسسےسےسسسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےےسسےسےسسےےسسسسےےسسےسےےےسسےسےسےسےےےسسسےےسسےسسےسسسےسسےسےسےےےسسےسےسےسےسےےےسےےےسےسسسسےےےسےےسسےسسےسسسسےسسےےےسسسےےسےسسےسےےےسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسےسسےسےسسےےسسےسےےسسےسےسےسسےسےسےسےسےسسسےےسسےسسےسسسےسسےسےسےسےسسےسےسےسےسےسےسےےےسےسسسسسسےسےےسسےسسےسسسسےسسےسےسسسےےسےسسےسےسےسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسےسسےےسےےسسےےسسےےسسےےسےسسسےےےےسسسےسسسسےسسےےےسےسسسےسسےسےسسےسسسےےےسےسےسسےسسےسےسےسسسےےےےسےسسسسےےےسسسسےسسسےسسسسےسسسےےےسسےسسسےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسسےےےسسسسسسسسسسسسسسسسسسےسسسسسسسسسسسسسسسسسسسسسسسسسےسسےےےےےسسسسسسسسسسسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسس‏ےصحصœ.“—+,ù®0شˆگ¨¸ہبذ ط àè ًّ  rنOn-screen ShowUniceflüƒ% « *TimesArialTimes New RomanSymbol New Brand(Procurement Overview and Tender ProcessTopics>UNICEF Vaccine Procurement Principles, Objectives and ProcessOur work is still…&UNICEF Vaccine Procurement Objectives,Additional specific GAVI tender objectives $GAVI vaccine Procurement Principles1General parameters of UNICEF vaccine procurement-The tender process (develop, issue, receipt)*The tender process (evaluation and award) Slide 11IPost-award Debriefings “What can we know about our competitor’s offer?”-Ensuring equal treatment, no bias and ethics)Strategic Issues on the upcoming tendersThree tenders for 2010-2012 Slide 16Middle Income countries (MICs)%Currency of proposals – USD vs. EUROForecasting Demand (Forecasting: Strategic and Operational *2009-2012 Strategic Forecast Methodology &Specifically for GAVI funded vaccinescThere are a number of activities undertaken to support Strategic and Operational Forecast accuracyForecast Challenges}The continuous changes in both supply and demand creates a dynamic market that requires continuous monitoring and managementThree tenders for 2010-2012 Thank you !&Overview of 2010-2012 Tender Document&Overview of 2010-2012 Tender Document&Overview of 2010-2012 Tender Document&Overview of 2010-2012 Tender Document Slide 326Why not ‘conditional awards’ for non-WHO PQ products?Proposals from ManufacturersProposal Evaluation ProcessTechnical Review of ProposalsPublic Notification of Awards  Fonts UsedDesign Template Slide Titles%ِ_ہ‘م^–ôkdorgankdorgan  !"#$%&'()*+,-./012‏ےےے456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~€پ‚ƒ„…†‡ˆ‰ٹ‹Œچژڈگ‘’“”•–—ک™ڑ›œ‌‍ں ،¢£¤¥¦§¨©ھ«¬­®¯°±²³´µ¶·¸¹؛»¼½¾؟ہءآأؤإئابةتثجحخدذرزسشصض×طظعغـفقكàلâمنهوçèéêëىيîïًٌٍَôُِ÷ّùْûü‎‏‏ےےے      !"#$%&'()‏ےےے+,-./01‏ےےے3456789‏ےےے‎ےےے‎ےےے‎ےےے>‏ےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےRoot Entryےےےےےےےےچپd›Oد†êھ¹)è‏ےےےPicturesےےےےےےےےےےےےêeCurrent Userےےےےےےےے2SummaryInformation(ےےےےےüTPowerPoint Document(ےےےےےےےےےےےے3‚–DocumentSummaryInformation8ےےےےےےےے*ےےےےےےےےےےےےےےےےےےےےےےےے